Glutamatergic synaptic plasticity na usoro mesocorticolimbic na-eri ahụ (2015)

Neurosci nke ihu n'ihu. 2015 Jenụwarị 20;8:466. doi: 10.3389/fncel.2014.00466. eCollection 2014.

Van Huijstee AN1, Onye isi ala HD1.

nkịtị

Ọgwụ na-eri ahụ na-emezigharị ụgwọ ọrụ ụbụrụ nke ụbụrụ, sistemu mesocorticolimbic dopamine (DA), site na ime mgbanwe ngbanwe nke glutamatergic synapses. A na-eche na plasticity synapti nke ọgwụ a na-akpata na-enye aka na mmepe na nkwụsi ike nke ịṅụ ọgwụ ọjọọ. Nlebanya a na-akọwapụta mgbanwe synapti nke na-ebute na vivo ikpughe na ọgwụ ndị na-eri ahụ ma na-akọwa otú mgbanwe synapti nke ọgwụ ndị a na-akpata nwere ike isi nye aka na akụkụ dị iche iche nke omume riri ahụ, dị ka ịṅụ ọgwụ ọjọọ n'agbanyeghị nsonaazụ ọjọọ na nlọghachi azụ. Na mbido, ikpughe ọgwụ na-eri ahụ na-ebute mgbanwe synapti na mpaghara ventral tegmental (VTA). Ike synapti nke ọgwụ a na-ebute na VTA na-emesị kpalite mgbanwe synapti na mpaghara mgbada nke sistemu mesocorticolimbic, dị ka nucleus accumbens (NAc) na cortex prefrontal (PFC), yana mkpughe ọgwụ ọzọ. A na-eche na mgbanwe ndị a glutamatergic synaptik na-emezigharị ọtụtụ n'ime mgbaàmà omume na-egosi riri ahụ. Oge ikpeazụ nke glutamatergic synaptic plasticity na NAc na karịsịa na PFC na-ekere òkè n'ịdowe ihe riri ahụ na ịghaghachi azụ n'ịṅụ ọgwụ na-akpalite site n'echiche metụtara ọgwụ. Mweghari nke sekit glutamatergic PFC nwere ike ịdịgide ruo n'oge okenye, na-ebute adịghị ike na-adịgide adịgide maka ịlaghachi azụ. Anyị ga-atụle ka mgbanwe neurobiological ndị a nke ọgwụ eji eme ihe na-emepụta nwere ike isi nye ebumnuche ọhụụ maka usoro ọgwụgwọ nwere ike ịme ahụ.

Keywords: riri ahụ, ọgwụ ọjọọ eme ihe, synapti plasticity, glutamate, dopamine, ventral tegmental area, nucleus accumbens, prefrontal cortex

Okwu Mmalite

Ruo ogologo oge, a naghị aghọta ịṅụ ọgwụ ọjọọ dịka ọrịa, kama dịka nhọrọ onwe onye. Ya mere, obere mbọ etinyere n'ịchọta usoro ọgwụgwọ kwesịrị ekwesị maka ndị dabere na ọgwụ. N'ime iri afọ ndị gara aga, ndị mmadụ achọpụtala na ọgwụ ndị na-eri ahụ na-akpata mgbanwe nrịanrịa n'ọrụ ụbụrụ, na iri ahụ ahụ bụ ọrịa ahụike na-adịghị ala ala. Ihe riri ahụ, ma ọ bụ "nsogbu iji ihe eji eme ihe" dị ka akọwara na DSM-5 (American Psychiatric Association, 2013A na-eji ọgwụ mmanye eme ihe n'agbanyeghị nsonaazụ ọjọọ yana ọnụ ọgụgụ nlọghachi azụ dị elu. N'ụwa niile, ihe dị ka nde mmadụ 27 bụ ndị na-eji ọgwụ opiates, cocaine, cannabis ma ọ bụ amphetamine na-akpata nsogbu yana 1 n'ime mmadụ 100 ọ bụla nwụrụ n'etiti ndị okenye na-ekwu na iji ọgwụ ọjọọ eme ihe (United Nations Office on Drugs and Crime). 2014). Ọzọkwa, WHO na-eme atụmatụ na ọnụ ahịa ọha mmadụ nke iji ọgwụ ọjọọ eme ihe bụ ihe dị ka 2% nke nnukwu ụlọ na 2004 na mba ndị tụlere ya (Òtù Ahụ Ike Worldwa, 2008). Ejikọtara ọtụtụ n'ime ụgwọ ndị a na mpụ metụtara ọgwụ. Ọ bụ ezie na mpaghara ọgwụ Europe ka kwụsiri ike n'afọ ndị na-adịbeghị anya, iji ọgwụ eme ihe na Europe ka dị elu site n'ụkpụrụ akụkọ ihe mere eme (EMCDDA, 2013). N'elu nke ahụ, ọnụ ahịa na ọnwụ na-esi na ya pụta kpọmkwem n'iji ọgwụ ndị mmadụ na-anakwere, dị ka ise siga na ịṅụ mmanya na-aba n'anya, buru ibu. Dị ka WHO si kwuo, ụtaba na-egbu ihe fọrọ nke nta ka ọ bụrụ nde mmadụ 6 kwa afọ yana nde mmadụ 3.3 na-anwụ kwa afọ n'ihi ịṅụ mmanya na-emerụ ahụ. Nke a anaghị eburu n'uche njikọ dị n'etiti ịṅụ mmanya na-emerụ ahụ na ise siga na ọtụtụ nsogbu uche na nke omume (Volkow na Li, 2005). N'ozuzu, ibu zuru ụwa ọnụ nke iri ahụ dị ukwuu. N'ụzọ dị mwute, ọgwụgwọ ugbu a maka ịṅụ ọgwụ ọjọọ riri ahụ ka na-adịchaghị irè. Iji meziwanye usoro ọgwụgwọ, ọ dị mkpa ịghọta nke ọma mgbanwe neurobiological nke na-akpata ahụ riri ahụ.

Ọ bụ ezie na sekit ụbụrụ na-eme ka ahụ riri ahụ dị mgbagwoju anya, o doro anya na ụgwọ ọrụ ụbụrụ na-akwụ ụgwọ, ma ọ bụ karịa, usoro mesocorticolimbic dopamine (DA), na-arụ ọrụ dị mkpa. Usoro mesocorticolimbic nwere mpaghara ventral tegmental (VTA) na mpaghara ụbụrụ nke na-ebute site na ntule sitere na VTA, dị ka nucleus accumbens (NAc), prefrontal cortex (PFC), amygdala, na hippocampus (Swanson, 1982). Usoro mesocorticolimbic dị oke mkpa maka nhazi ụgwọ ọrụ na nkwado nkwado, mkpali, na omume eduzi ebumnuche (Schultz, 1998; Onye maara ihe, 2004). Ọgwụ niile na-eri ahụ na-arụ ọrụ na sistemu mesocorticolimbic, na-abawanye ọkwa DA na sistemụ a (Di Chiara na Imperato, 1988). Ụdị ọgwụ dị iche iche na-abawanye ọkwa mesocorticolimbic DA site na usoro cellular dị iche iche. Nicotine na-abawanye ọkwa DA site na ịkpali VTA DA neurons ozugbo site na α4β2-nwere nicotinic anabata (Maskos et al., 2005). Ọtụtụ ọgwụ ndị ọzọ, dị ka benzodiazepines, opioids na cannabinoids, na-egosipụta mmetụta ha site na igbochi GABAergic interneurons na VTA, si otú ahụ belata mgbochi na neurons DA (Johnson na North, 1992; Szabo et al., 2002; Tan et al., 2010). Psychostimulants, dị ka cocaine na amphetamine, na-abawanye ọkwa DA extracellular site na iso ndị na-ebugharị DA na-emekọrịta ihe, si otú a na-egbochi DA reuptake (Williams na Galli, 2006). Mmụba na ọkwa mesocorticolimbic DA na-ebute oke mmetụta ike nke ọgwụ na-eri ahụ. Otú ọ dị, ọ naghị akọwa ihe ọjọọ omume na-adịte aka nke a na-ahụ na ịṅụ ọgwụ ọjọọ, ebe ọ bụ na ndị a ka dị mgbe a kpochapụrụ ọgwụ ndị ahụ n'ahụ na ọkwa DA laghachiri na nkịtị. Mmepe na ngosipụta nke omume riri ahụ sitere na neuroadaptations ọgwụ na-adịgide adịgide na sistemu mesocorticolimbic.

Mgbakọta ihe akaebe na-egosi na ọgwụ ọjọọ na-ebute mgbanwe na-adịte aka n'ụbụrụ. Kpọmkwem, ọgwụ ọjọọ eme ihe na-agbanwe nnyefe synapti na sistemụ mesocorticolimbic. A na-akpọ ihe a na-akpata ọgwụ synaptic plasticity (Lüscher na Malenka, 2011). Nyocha a na-elekwasị anya na synapti plasticity kpaliri na vivo ikpughe ọgwụ ọjọọ eme ihe. Ọ bụ ezie na ọgwụ ndị na-eri ahụ na-agbanwe ọtụtụ ụdị synapses, a na-eche na ọgwụ ndị na-eri ahụ na-agbanwekarị nnyefe glutamatergic (Lüscher, 2013). Ọzọkwa, ọgwụ synapti plasticity nke nnyefe glutamatergic amụrụla nke ukwuu. Anyị ga-akọwapụta nchoputa n'oge na-adịbeghị anya banyere ọgwụ synaptik plasticity nke nnyefe glutamatergic, na ebumnuche ịkọwapụta ihe usoro ndị a na-emekarị n'azụ mmegharị synapti ndị a bụ, yana ka mgbanwe synapti ndị a sitere na ọgwụ na-enye aka na akụkụ dị iche iche nke omume riri ahụ.

Mgbanwe mmalite na nnyefe synapti

Plasticity synapti na mpaghara ventral tegmental (VTA)

Mgbanwe na nnyefe synapti emelarị mgbe mkpughe mbụ na ọgwụ na-eri ahụ. Otu otu na vivo ikpughe na ọgwụ na-eri ahụ na-ebute mmụba nke ike synapti na glutamatergic synapses na DA neurons nke VTA. A na-enye otu ntụtụ cocaine na-anaghị akwụsị akwụsị na vivo na ụmụ oke na oke, na 24 h mgbe e mesịrị, a na-edekọ mmiri na-akpali akpali postsynaptic (EPSCs) na dopaminergic neurons na midbrain mpekere nke ụmụ anụmanụ ndị a iji nyochaa mgbanwe na ike synapti (Ungless et al., 2001). Oke nke AMPAR- vs. NMDAR-mediated EPSCs (AMPAR/NMDAR ratio) na VTA DA neurons abawanyela nke ukwuu. Mmụba a nwere ike igosipụta mmụba na mmiri AMPAR ma ọ bụ mbelata na mmiri NMDAR ma ọ bụ ngwakọta nke abụọ. N'ezie, mmụba AMPAR na mbelata mmiri NMDAR na-eme ma na-ebute mmụba AMPAR/NMDAR mgbe ekpughere ọgwụ na-eri ahụ. N'agbanyeghị et al. (2001gosipụtara na mgbasa ozi AMPAR na-abawanye na glutamatergic synapses na DA neurons nke VTA, ebe ọ bụ na njupụta na ugboro ole nke AMPAR-mediated miniature EPSCs (mEPSCs) mụbara nke ukwuu mgbe e mesịrị. na vivo ikpughe na cocaine. Nke a kwadoro site na nchọta nke etinyere AMPA na VTA DA neurons butere nnukwu mmiri iyi AMPA na-ebute na mpekere sitere na ụmụ oke ndị natara ọgwụ cocaine karịa n'iberibe sitere na ụmụ oke ndị e tinyere saline. N'ụzọ dị mkpa, a na-egosipụta ike ogologo oge nke cocaine na-eme ka ikuku mgbasa ozi AMPAR bụrụ kpọmkwem maka DA neurons nke VTA, ebe ọ bụ na enweghi ike ịchọta na hippocampus ma ọ bụ na GABA neurons na VTA. Mmụba nke Cocaine na-abawanye na nha AMPAR / NMDAR emeghị mgbe a na-ejikọta cocaine na onye na-emegide NMDAR, na-egosi na mmụba nke AMPAR / NMDAR ruru dabere na ntinye NMDAR. Ya mere, otu ikpughe na cocaine na-ebute plasticity synaptik na synapses na-akpali akpali na VTA DA neurons nke yiri NMDAR-adabere ogologo oge ike (LTP). N'ikwekọ na nke a, plasticity synapti nke ọgwụ na-ekpuchi LTP na-esote, na-atụ aro na ụdị abụọ a nke plasticity na-ekerịta usoro dị n'okpuru (Ungless et al., 2001; Liu et al., 2005; Argilli et al., 2008; Luu na Malenka, 2008).

Mgbe nchọpụta nke na vivo Plasticity nke cocaine kpatara, a nyochara ma ọgwụ ndị ọzọ eji eme ihe na-akpata otu mgbanwe ahụ na nnyefe excitatory na VTA. Site na na vitro Ọmụmụ ihe a maralarị na ntinye nke nicotine dị ntakịrị na-akpalite LTP na synapses na-akpali akpali na VTA DA neurons (Mansvelder na McGehee, 2000), na-akwado echiche a. N'ezie, ọgwụ niile na-eri ahụ nwalere ruo taa (n'ime nke morphine, nicotine, benzodiazepines na ethanol) na-ebute ike nke nnyefe AMPAR na VTA DA neurons 24 h mgbe na vivo nchịkwa nke otu dose (Saal et al., 2003; Tan et al., 2010). Enweghi oke AMPAR/NMDAR ka emechara na vivo nchịkwa nke ọgwụ psychoactive na-adịghị eri ahụ fluoxetine na carbamazepine (Saal et al., 2003). Eziokwu ahụ bụ na klas ọgwụ dị iche iche, nke nwere usoro ihe omume dị iche iche, na-ebute ụdị ụdị synaptic plasticity na VTA DA neurons bụ ihe mbụ gosiri na ụdị synaptic plasticity a nwere ike jikọta ya na ihe na-eri ahụ nke ọgwụ ndị a.

Nnyocha ndị ọzọ n'ime usoro ndị na-akpata mmụba AMPAR / NMDAR gosipụtara na NMDAR-arụ ọrụ achọrọ maka plastik synapti nke ọgwụ na-ebute site na mkpali nke DA D.5 ndị na-anabata ya, ebe ọ bụ na ọ nweghị ike ịkpata cocaine ka achọpụtara mgbe itinyechara D1/D5 receptor antagonist ma ọ bụ na D5 ụmụ oke na-anabata knockout (Argilli et al., 2008). Plasticity synapti nke Nicotine kpatara na vitro dabere na DA D5 ndị na-anabata ya (Mao et al., 2011). A na-ebute mgbasa ozi AMPAR site na ntinye nke AMPAR enweghị GluA2 n'ime synapse na-eso. na vivo ikpughe ọgwụ ndị na-eri ahụ (Bellone na Lüscher, 2006; Argilli et al., 2008). Ọrụ mbụ nke Fitzgerald et al. (1996) enyelarị ihe ngosi na plasticity nke ọgwụ na-ebute na glutamatergic synapses na DA neurons nke VTA gụnyere mgbanwe na GluA2-enweghị AMPAR. Nkwupụta nke ngalaba GluA1, mana ọ bụghị ngalaba GluA2, abawanyela na VTA DA neurons mgbe ekpughere ya na cocaine (Fitzgerald et al., 1996). Ịchọta ihe akaebe kpụ ọkụ n'ọnụ nke mgbanwe gaa na AMPAR enweghị GluA2, Bellone na Lüscher (2006) ejirila njirimara biophysical pụrụ iche nke AMPAR enweghị GluA2. AMPAR enweghị GluA2 bụ Ca2+-permeable, nwere omume ka ukwuu, na-edozi n'ime ime ma na-egbochi ya site na polyamines (Washburn na Dingledine, 1996; Isaac et al., 2007). Ndozi nke EPSC nke AMPAR na-emekọrịta ihe na-abawanye na-esochi nchịkwa cocaine, na nchịkwa nke polyamine toxin Joro spider toxin (JST) na-egbochi EPSC nke AMPAR na-emekọrịta ihe na ụmụ oke ndị na-agwọ cocaine, na-akwado ntinye nke GluA2-enweghị AMPARs (Bellone na Lüscher). 2006). Enwere ike itinye ndị nnabata ndị a n'elu ọdọ mmiri GluA2 nwere AMPAR dị ugbu a ma ọ bụ ha nwere ike dochie ndị nnabata GluA2 nwere, na-edobe ngụkọta nke AMPAR na synapse mgbe niile. Immunogold labeling nke GluA2 subunits gosiri na ọdọ mmiri cytoplasmic nke GluA2 nwere AMPAR ka emelitere mgbe ekpughere ya na cocaine, ebe akara GluA2 na synapse belatara (Mameli et al., 2007). Ya mere, ikpughe na ọgwụ na-eri ahụ na-akpata mgbanwe nke GluA2-nwere maka GluA2-enweghị AMPARs, nke na-eme ka nnyefe AMPAR dị elu n'ihi otu ọwa dị elu nke GluA2-enweghị AMPAR.

Na mbụ, ọmụmụ ndị kọrọ na ike ọgwụ sitere na mgbasa ozi mgbasa ozi AMPAR na VTA DA neurons ka emere awa 24 mgbe nchịkwa ọgwụ gasịrị, mana kedu oge n'ezie nke synapse na-ewusi ike na-eso mkpughe ọgwụ? Argilli et al. (2008) chọpụtara na plastik synapti mere ngwa ngwa mgbe nchịkwa gasịrị, ebe ọ bụ na ahụrụ ike AMPAR dị n'ime awa 3 (Argilli et al., 2008). Plastic synapti nke Cocaine kpatara na-adịru nwa oge, ebe ọ bụ na a ka na-ahụ ike synapti ka ụbọchị 5 gachara, mana ọ bụghị mgbe ụbọchị iri gachara (Ungless et al., 2001). Ebe ọ bụ na nnyefe na glutamatergic synapses na VTA DA neurons bụ nke a na-ahazi mgbe ihe dị ka otu izu gasịrị, a ga-etinyerịrị usoro na-egbochi mgbanwe ndị ọgwụ ahụ kpatara. N'ụzọ na-akpali mmasị, a na-atụgharị synapti plasticity nke cocaine site na ịgbalite ndị na-anabata mGluR1 na VTA. Kpọmkwem, ịgba ọgwụ intraperitoneal nke ezigbo modulator nke mGluR1 weghaara nkesa subunit AMPAR nke cocaine kpatara (Bellone na Lüscher, 2006). Mgbagha mpaghara nke ọrụ mGluR1 na neurons nke VTA n'aka nke ọzọ mere ka ike cocaine kpalitere na VTA (Mameli et al., 2009). Ya mere, na-esochi ikpughe na ọgwụ, glutamatergic synaptic nnyefe bụ nke mGluR-based LTD na-emezigharị, nke mejupụtara ngbanwe nke AMPAR na-enweghị GluA2 nwere obere omume GluA2 nwere AMPAR (Mameli et al., 2007).

Ka ọ dị ugbu a, a tụlere mgbasa ozi AMPAR ka ọ bụrụ ihe kpatara mmụba AMPAR/NMDAR na-ebute site na. na vivo ikpughe ọgwụ. Agbanyeghị, ntinye nke AMPAR enweghị GluA2 ga-ebelata oke AMPAR/NMDAR na +40 mV, ebe ọ bụ na AMPAR enweghị GluA2 na-eme nke ọma na ikike akpụkpọ ahụ dị mma n'ihi ngọngọ polyamine. Ya mere, mmụba nke AMPAR/NMDAR ga-abụrịrị ihe kpatara ya site na mbelata n'ọnụ mmiri NMDAR. N'ezie, a chọpụtakwara na ọnụọgụ AMPAR/NMDAR mụbara bụ n'ihi mbelata mgbasa ozi NMDAR (Mameli et al., 2011). Mbelata nke a sitere na ngbanwe nhazi nke subunit NMDAR. Ọnụ ọgụgụ GluN2B na GluN2A na-abawanye na-esochi ikpughe na cocaine (Yuan et al., 2013). Ọzọkwa, NMDAR nke GluN3A nwere, nke nwere Ca2+ permeability, na-etinye n'ime synapse mgbe ikpughe cocaine (Yuan et al., 2013). Ọnụ, nchoputa ndị a na-egosi na cocaine na-eme ka ntinye synapti nke tri-heteromeric GluN1/GluN2B/GluN3A nwere NMDAR nke dochie GluN1/GluN2As na GluN1/GluN2A/ GluN2Bs. Achọpụtara mgbanwe abụọ a na-akpata cocaine na nnyefe AMPAR na mgbanwe cocaine kpatara na nnyefe NMDAR dabere na ntinye nke GluN3A nwere NMDAR, ebe ọ nweghị plasticity nke cocaine dị na ụmụ oke GluN3A knockout ma ọ bụ mgbe ịgbanye ọgwụ nje metụtara adeno. vector na-ekwupụta mgbochi GluN3A mkpụmkpụ ntutu isi RNA (Yuan et al., 2013). N'ikpeazụ, mGluR1 na-arụ ọrụ, nke na-atụgharị ntụgharị nke AMPAR nke cocaine na-ebute, gbanwekwara redistribution nke NMDAR (Yuan et al., 2013). Ya mere, ntinye synapti nke GluN3A nwere AMPAR dị ka ọ dị mkpa maka ngosipụta nke plasticity nke cocaine kpatara.

Na mgbakwunye na ntinye glutamatergic, VTA DA neurons na-enwetakwa ntinye GABAergic, site na interneurons mpaghara yana amụma sitere na NAc na ventral pallidum (VP; Kalivas et al., 1993; Steffensen et al., 1998). Synapses inhibitory ndị a na VTA DA neurons na-enwetakwa plastik synapti mgbe ekpughere ọgwụ na-eri ahụ. E gosipụtara Morphine, cocaine na nicotine niile iji mebie ike ogologo oge nke GABAergic synapses na VTA DA neurons, n'agbanyeghị na usoro oge dị iche iche (Niehaus et al., 2010). N'aka nke ọzọ, ntinye GABAergic na interneurons inhibitory na VTA na-enwe ike mgbe e mesịrị. na vivo ikpughe ọgwụ ọjọọ, si otú a na-egbochi neurons DA (Tan et al., 2010; Bocklisch et al., 2013). Ọnụ, ụbara AMPAR / NMDAR na glutamatergic synapses na VTA DA neurons, mfu nke LTP nke GABAergic synapses na VTA DA neurons, yana nkwụsị nke VTA DA neurons site na ike nke GABAergic synapses na VTA interneurons nwere ike ime ka ọ dịkwuo mma. VTA DA neurons. N'ihe banyere nicotine, ntinye GABAergic na VTA DA neurons na-ebelatakwa site na nhụsianya nke nicotinic acetylcholine receptors (nAChRs) na neurons GABAergic (Mansvelder et al., 2002). Ebe ọ bụ na ịgbalite nAChRs depolarizes neurons GABAergic, nhụsianya a na-eduga na ịda mbà n'obi nke nnyefe GABAergic. Mmetụta a bụ nke kachasị na mpaghara nke neurons GABAergic nke na-enwekarị mmasị site na nnyefe cholinergic endogenous. Mmetụta ịda mbà n'obi nke ntinye GABAergic n'ihi nAChR desensitization nwere ike inye aka na mmụba na VTA DA neuron excitability, ọ bụ ezie na mmekọrịta dị mgbagwoju anya n'etiti GABA na DA neuron ọrụ yiri ka ọ na-ekere òkè (Tolu et al., 2013).

Plastic synapti nke ọgwụ na-akpata na VTA anaghị eme n'ụwa niile, na-emetụta akwara VTA DA niile n'otu aka ahụ. Nchoputa na nso nso a egosila na ọgwụ dị iche iche na-emetụta ọnụ ọgụgụ dị iche iche nke VTA DA neurons na amụma na mpaghara iche iche. (Lammel et al., 2013). Otu ntụtụ nke cocaine ahọpụtara glutamatergic synapses na DA neurons na-atụpụta na shei NAc mana ọ bụghị synapses na DA neurons na-atụpụta na mPFC (Lammel et al., 2011). Agbanwere synapses na-akpali akpali na DA neurons na-emepe na mPFC site na mkpali na-akpali akpali, na-atụ aro na ihe mkpali na-akwụghachi ụgwọ na nke mgbagha na-emetụta ọnụ ọgụgụ DA neuron dị iche iche na VTA. Ndị neurons DA na-atụba na shea NAc, nke ọgwụ na-emetụta, na-enweta ntinye ha site na tegmentum laterododorsal, ebe DA neurons na-atụpụta na mPFC, nke ihe mkpali na-emetụta, na-enweta ntinye ha site na habenula mpụta (Lammel et al. ., 2012).

Single na vivo ikpughe na ọgwụ ọjọọ eme ihe na-ebute mgbanwe synaptik nke ka dị ogologo oge ka ekpochapụchara ọgwụ ndị ahụ n'ahụ, ọ dịkarịa ala ụbọchị 5. Otú ọ dị, nke a adịghị adịte aka iji kọwaa mmetụta omume na-adịte aka nke a na-ahụ na ịṅụ ọgwụ ọjọọ. EỌbụna mgbe nchịkwa cocaine ugboro ugboro (ịgba ọgwụ asaa kwa ụbọchị), mmụba nke cocaine kpatara na AMPAR / NMDAR ruru na VTA DA neurons na-adịru nwa oge, a pụghịkwa ịhụ ya ụbọchị iri ka nkwụsị nke nchịkwa cocaine gasịrị, dị ka ike synapti kpatara site na. otu injection (Borgland et al., 2004). Agbanyeghị, n'ime ọmụmụ ihe ndị a niile, a na-eji nchịkwa ọgwụ na-anaghị akwụsị akwụsị. Mmetụta nke nchịkwa onwe onye nke ọgwụ ndị na-eri ahụ na-adịte aka karịa mmetụta nchịkwa ọgwụ na-adịghị agwụ agwụ. Mgbe ọnwa 3 nke abstinence na nchịkwa onwe nke cocaine, ike synapti nke cocaine ka dị na VTA DA neurons na oke. (Chen et al., 2008). Nnọgidesi ike nke ike synaptik nke ọgwụ na-akpata na neurons VTA mgbe nchịkwa onwe onye ọgwụ gasịrị na-egosi na ihe a nwere ike ịbụ isi ihe na-ebute mmepe nke omume riri ahụ.

Gịnị bụ mgbanwe akparamagwa nke na-ebute site na plasticity synapti nke ọgwụ na-ebute na VTA? Ụmụ oke nwere mkpochapụ mkpụrụ ndụ ihe nketa nke ngalaba GluA1 ma ọ bụ ngalaba GluN1 na-ahọrọ na DA neurons enweghị ike ọgwụ na-akpata ọgwụ na VTA DA neurons, mana cocaine ka na-ebute mmasị ọnọdụ ọnọdụ nkịtị (CPP) na mmetụta omume. n'ime ụmụ oke ndị a (Engblom et al., 2008). N'ọmụmụ ihe ọzọ, ụmụ oke na-enweghị ngalaba GluN1 naanị na DA neurons gosikwara mmetụta omume nkịtị, mana kagburu CPP na ụmụ oke ndị a (Zweifel et al., 2008), dị iche na nsonaazụ si Engblom et al. (2008). Nke a dị iche n'etiti ọmụmụ ihe nwere ike ịkpata ọdịiche dị na protocol CPP. N'ihe niile, ihe akaebe na-egosi na plasticity synaptic nke ọgwụ na-ebute na VTA DA neurons na-eme ka mmetụta omume dị mkpirikpi nke ikpughe ọgwụ dị oke oke. Agbanyeghị, plastik synapti nke ọgwụ butere na VTA DA neurons nwere ike ịbụ nzọụkwụ mbụ dị mkpa maka omume riri ahụ n'oge. N'ime ụmụ oke enweghị GluN1 na neurons DA, mweghachi nke omume ịchọ ọgwụ na CPP kwụsịrị (Engblom et al., 2008). Ọzọkwa, mmụba na-egbu oge nke nleba anya omume nke na-eme mgbe ndọpụ cocaine ogologo oge emeghị na ụmụ oke GluN1 knockout (Zweifel et al., 2008). Mgbanwe omume omume ndị a na-eme n'oge na-adịbeghị anya nwere ike ọ bụghị kpọmkwem nsonaazụ nke synapti plasticity na VTA, mana ọ ga-abụ na mgbanwe synapti na mpaghara ụbụrụ ndị ọzọ na-ebute site na synaptic plasticity na VTA. Plastic synaptic nke ọgwụ na-akpata na VTA na-eduga na synaptic plasticity na-esote na mpaghara ụbụrụ ndị ọzọ, nke dị mkpa maka mgbanwe omume a na-ahụ na ịṅụ ọgwụ ọjọọ karịa synaptic plasticity na VTA n'onwe ya (lee n'okpuru). Na VTA, ọgwụ ọjọọ eme ihe na-agbanwe iwu maka plasticity dabere na ọrụ ma si otú a mee ka mgbanwe ndị na-esote ala na-esote na mesocorticolimbic circuitry (Creed na Lüscher, 2013). Tmgbanwe hese na mpaghara ụbụrụ dị n'okpuru, ọkachasị na NAc na PFC, a na-eche na ọ ga-ejikọta ya na ajọ omume omume na-adịte aka nke a na-ahụ na iri ahụ.

Ikike nke plastic synapti nke ọgwụ na-ebute na VTA iji tụgharịa iwu maka plasticity dabere na ọrụ na-adabere na nkesa nke AMPAR na NMDAR subunits (Yuan et al., 2013). Dị ka ọ na-adịkarị, LTP na-adabere na NMDAR ma na-akpali ya mgbe mwepụta presynaptic glutamate dakọtara na depolarization nke akpụkpọ ahụ postsynaptic, n'ihi na Mg.2+-block nke NMDARs na-enwere onwe ya na ikike akpụkpọ ahụ mebiri emebi, na-enye ohere Ca2+ ntinye. Agbanyeghị, cocaine na-ebute ngbanwe nke ihe mejupụtara NMDAR, na-eke NMDAR nwere obere Ca2+ permeability (Yuan et al., 2013). Ya mere, ịgbalite NMDARs anaghịkwa ebute LTP. N'aka nke ọzọ, cocaine na-ebugharị ntinye synapti nke GluA2-enweghị AMPAR, nke bụ Ca.2+- permeable. Ya mere, mgbe ikpughe cocaine gasịrị, ụdị LTP nwere ike ịkpata na VTA neurons nke na-adabere na ntinye calcium site na AMPAR ma na-adabere na NMDAR (Mameli et al., 2011). Agbanyeghị, AMPAR na-enweghị GluA2 na-eme nke ọma na ikike akpụkpọ ahụ dị mma, n'ihi mgbochi polyamine na ikike akpụkpọ ahụ dị mma. Ka hyperpolarization na-abawanye, ka GluA2 enweghị AMPAR na-eme calcium ngwa ngwa. Ya mere, cocaine na-eme ka iwu nke ike synaptic dabere na ọrụ gbanwee, ebe ọ bụ na ntinye nke LTP chọrọ ugbu a ijikọ ọrụ presynaptic na hyperpolarization nke cell postsynaptic kama depolarization (Mameli et al., 2011). A ka ga-anwale ma nke a ọ̀ bụ eziokwu maka ọgwụ ọjọọ niile.

Dịka e kwuru n'elu, glutamatergic synaptic plasticity na VTA na-ebute plasticity synapti na-esote n'akụkụ ndị ọzọ nke usoro mesocorticolimbic. Mgbanwe synaptik na-ebute ụzọ na VTA tupu synaptic plasticity na mpaghara ndị ọzọ nke mesocorticolimbic usoro. Na mgbakwunye, mgbanwe na VTA na-eme mgbe otu ikpughe, ebe plasticity na mpaghara ala na-achọkarị ikpughe ọgwụ. (Kourrich et al., 2007), ọ bụ ezie na ọ dị mkpa ka a mara na Mato et al. (2004) gosiri na na ụmụ oke, otu na vivo nchịkwa nke THC gbanwere synaptic plasticity na NAc (Mato et al., 2004). Ọzọkwa, cocaine-evoked synaptic plasticity na NAc na-eme naanị ma ọ bụrụ na synaptic plasticity na VTA na-adịgide adịgide. (Mameli et al., 2009). Ntughari plasticity synapti na VTA site na intraperitoneal injections nke ezigbo modulator nke mGluR1 gbochiri synaptic plasticity na NAc (Mameli et al., 2009). N'aka nke ọzọ, mgbe nkwụsị nke mpaghara mGluR1 na-arụ ọrụ na VTA neurons, nke na-agbatị ike nke ọgwụ na-ebute na VTA, otu injection nke cocaine zuru ezu iji mee ka synaptic plasticity na NAc, nke na-adịghị emekarị. Nchọpụta ndị a na-atụ aro ụlọ ọrụ nhazi nke synaptic plasticity na-ebute ọgwụ, yana VTA dị ka ebe mbụ nke plasticity, na-esote glutamatergic synaptic plasticity na mpaghara ala nke usoro mesocorticolimbic. A na-atụle usoro ndị dị n'okpuru usoro nke plasticity n'ikpeazụ na ngalaba na-esonụ.

Oge ọzọ nke nrụgharị synapti

Plastic synapti nke sitere na ọgwụ na-eme n'ime nucleus accumens

Ndị isi akwara nke NAc, GABAergic medium spiny neurons (MSNs), na-enweta ntinye glutamatergic sitere na mpaghara ụbụrụ cortical na limbic, gụnyere PFC na amygdala. (Groenewegen et al., 1999). Nsonaazụ sitere na ọtụtụ ọmụmụ na-egosi na nnyefe glutamatergic na NAc na-arụ ọrụ dị mkpa n'ịchọ ọgwụ. Microinjection nke AMPA n'ime NAc na-eme ka mweghachi dị ukwuu nke omume ịchọ cocaine, ebe microinjection nke onye na-emegide AMPAR n'ime NAc na-egbochi iweghachite cocaine na-achọ (Cornish na Kalivas, 2000; Ping et al., 2008). Ọzọkwa, a na-eche na ọrụ dị n'ime NAc na-emezi nghọta omume (Koya et al., 2009, 2012). Ebe ọ bụ na akara ngosi glutamatergic na NAc na-arụ ọrụ dị mkpa na omume riri ahụ, plasticity synaptik na glutamatergic synapses na NAc MSN nwere ike itinye aka na riri ahụ.

N'adịghị ka VTA, otu injection cocaine ezughi oke iji kpalite plasticity synapti na NAc (Kourrich et al., 2007). Naanị mgbe ọgwụgwọ cocaine gasịrị ugboro ugboro, mgbanwe na ike synapti na-eme na glutamatergic synapses na NAc MSNs.. Ntuziaka nke plastic synapti a dabere na ogologo oge nkwụsị ọgwụ (Kourrich et al., 2007). Kourrich et al. (2007) na-enye ụmụ oke ọgwụ cocaine ise otu ugboro kwa ụbọchị wee nyochaa nha AMPAR / NMDAR na neurons NAc ma 24 h na 10-14 ụbọchị mgbe ntụtụ ikpeazụ gasịrị. N'oge mwepu n'oge, 24 h mgbe ịgba ọgwụ ikpeazụ gasịrị, ahụrụ mbelata dị ukwuu na oke AMPAR / NMDAR na akwara NAc shell nke ụmụ oke a na-agwọ cocaine. Agbanyeghị, mgbe oge enweghị ọgwụ nke ụbọchị 10–14, abawanyela oke AMPAR/NMDAR na neurons shei NAc. Ọzọkwa, otu mkpugheghachi ọgwụ ọjọọ mere ka mbelata na nha AMPAR/NMDAR 1 ụbọchị ka e mesịrị, na-atụgharị na mberede ike synapti. Mmetụta ịda mbà n'obi nke synapti na-esochi mkpughe cocaine ọzọ mgbe oge enweghị ọgwụ na-akọwakwa na ọmụmụ mbụ (Thomas et al., 2001; Brebner et al., 2005). Thomas et al. (2001) gosikwara na mbelata nke nha AMPAR/NMDAR na-egosipụta mbelata mgbasa ozi AMPAR.

Iji chọpụta ihe kpatara mmụba AMPAR / NMDAR na neurons NAc shei mgbe ogologo oge ewepụrụ, Kourrich et al. (2007) mEPSC ndị mgbasa ozi AMPAR dekọrọ. Ọnụ ọgụgụ na ugboro nke mEPSC nke AMPAR na-emekọrịta ihe na-abawanye nke ọma na ụmụ oke ndị na-agwọ cocaine (Kourrich et al., 2007), na-atụ aro ike nke mgbasa ozi synapti nke AMPAR na-eme ka ọ nwesịrị ogologo oge. Nsonaazụ ndị a dabara na nchoputa nke Boudreau na Wolf (Boudreau na Wolf, 2005), onye chọtara ngosipụta elu cell nke AMPAR dị na NAc nke oke mgbe ụbọchị 21 nwechara. Ọ bụ ezie na kpọmkwem usoro ndị na-akpata ike synapti nke ọgwụ a na-akpata na NAc shei mgbe ọ kwụsịrị ogologo oge, amataghị na ike synapti dabere na ịgbalite ụzọ kinase (ERK) na-achịkwa extracellular site n'ụzọ ERK phosphorylation. (Pascoli et al., 2012). Ugboro ugboro nke AMPAR mEPSCs, jikọtara ya na nchọpụta na ọnụọgụ abụọ-pulse (ihe maka ọrụ presynaptic) agbanweghị, na-atụ aro na ikpughe na cocaine ugboro ugboro nwere ike iduga n'ichepụta synapses ọhụrụ na NAc MSN. A na-akwado nke a site na nchọpụta na ọnụ ọgụgụ dendritic spines na NAc MSN mụbara mgbe ekpughere ya ugboro ugboro na cocaine, amphetamine na nicotine (Robinson na Kolb, 2004). Ya mere, ikpughe cocaine ugboro ugboro na-emepụta ike synaptik na shea NAc nke na-etolite n'oge nkwụsị ọgwụ, ikekwe n'ihi nhazi nke synapses ọhụrụ, bụ nke ịda mbà n'obi synaptik na-esote n'otu oge ọzọ. Otú ọ dị, ma mgbe nkwụsịtụ ogologo oge gasịrị na mgbe ekpughere otu ọgwụ ọzọ, nnyefe NMDAR agbanweghị (Kourrich et al., 2007). Ọzọkwa, ọ nweghị ihe akaebe maka mgbanwe na ọnụnọ GluA2-enweghị AMPAR na synapse ahụ, ebe ọ bụ na EPSCs na-emezigharị nke AMPAR na-agbanwe agbanwe agbanweghị na ụmụ oke na-agwọ cocaine mgbe ọ gbasasịrị ogologo oge na mgbe ekpughere cocaine ọzọ.

Ọmụmụ ihe ndị a na-eji nchịkwa ọgwụ na-adịghị akwụsị akwụsị iji kpalite plasticity synapti. N'ịgbaso nchịkwa onwe onye cocaine, a chọtara ịda mbà n'obi synaptik nke mgbasa ozi na-akpali akpali na NAc shei n'oge mwepụta mbụ na cocaine (Schramm-Sapyta et al., 2006), bụ nke na-esochi mgbasa ozi AMPAR na-abawanye mgbe ọ kwụsịrị ogologo oge (Conrad et al., 2008). Agbanyeghị, n'adịghị ka nchoputa nke Kourrich et al. (2007), Achọpụtara mmụba a n'ihi ntinye synapti nke GluA2 enweghị AMPAR. Belu ọzọ na intracellular GluA1 ọkwa abawanyela nke ukwuu na NAc mgbe ụbọchị 45 nke ndọrọ ego gasịrị, na imezi mmezi nke EPSC nke AMPAR na-emekọrịta ihe na-abawanye nke ukwuu na isi NAc nke oke oke cocaine (Conrad et al., 2008). Agbanweghị ọkwa GluA2, na-atụ aro na etinyere AMPAR enweghị GluA2 n'elu ọdọ mmiri GluA2 nwere AMPAR dị ugbu a. Ebe ọ bụ na Kourrich et al., enyocha mgbanwe synaptik mgbe 10-14 ụbọchị wepụrụ, ebe Conrad et al. enyocha mgbanwe synapti mgbe 42-47 ụbọchị wepụrụ, ọ ga-ekwe omume na ntinye synapti nke GluA2-enweghị AMPAR na NAc na-eme naanị mgbe ogologo oge nkwụsị. Nke a dabere na nchoputa na ọkwa NAc GluA1 ka abawanyela ntakịrị ka ụbọchị 21 ewepụrụ, na-egosi na ọkwa GluA1 na-abawanye nke nta nke nta ka ewepụrụ (Conrad et al., 2008). Ọmụmụ nke Mameli et al. (2009) na-akwado echiche ahụ A na-etinye AMPAR na-enweghị GluA2 n'ime synapses ka agbatịchara ogologo oge na ikpughe cocaine ugboro ugboro.. Achọtara nrụzi mmezigharị na NAc MSN mgbe ụbọchị 35 nke ndọrọ ndọrọ ọchịchị gasịrị mgbe nchịkwa cocaine na-enweghị isi na nchịkwa onwe nke cocaine (Mameli et al., 2009). Yabụ, ọkwa subunit AMPAR synapti na NAc MSN na-agbanwe ruo ọtụtụ izu na-eso mkpughe cocaine.

Ma Thomas et al. (2001) na Kourrich et al. (2007) hụrụ mbelata dị ukwuu na oke AMPAR / NMDAR na NAc shell neurons nke ụmụ oke a na-agwọ cocaine n'oge mwepụta mbụ, nke ekwuru na mbelata na nnyefe AMPAR (Thomas et al., 2001). Agbanyeghị, oke AMPAR/NMDAR belatara nwekwara ike bute ya site na ọgbọ nke synapses gbachiri nkịtị. Synapses gbachiri nkịtị bụ glutamatergic synapses nwere NMDAR, mana enweghị AMPAR na-arụ ọrụ (Isak et al., 1995). Thomas et al. (2001) ahụghị mgbanwe ọ bụla na-akpata cocaine na nnyefe NMDAR, ma nke a anaghị ewepu ohere na ọnụ ọgụgụ nke synapses na-agbachi nkịtị na-abawanye site na ikpughe cocaine. N'ezie, na-esochi ikpughe cocaine na-adịghị agbanwe agbanwe ugboro ugboro, ọnụọgụ synapses gbachiri nkịtị na-abawanye na NAc shell MSNs (Huang et al., 2009). Eji nwayọọ nwayọọ mepụta synapses ọhụrụ ndị a na-agbachi nkịtị n'oge ikpughe cocaine, na-eme ka mmụba dị ukwuu na pasent nke synapses dị jụụ site na ụbọchị nke atọ nke ọgwụgwọ cocaine. Ọgbọ nke cocaine kpatara synapses gbachiri nkịtị bụ onye ogbugbo site na ntinye akpụkpọ anụ nke GluN2B nwere NMDAR ọhụrụ (Huang et al., 2009). Mbara elu na mkpokọta ọkwa GluN2B, mana ọ bụghị GluN2A, ka abawanyela, yana mgbakwunye elu elu nke subunits GluN1. Ọzọkwa, mgbe ahọpụtara igbochi GluN2B nwere NMDAR nke nwere, enweghị mmụba na synapses nkịtị enweghị ike ịchọpụta. N'oge ndọrọ ndọrọ ọchịchị, ọnụ ọgụgụ synapses gbachiri nkịtị jụrụ ọzọ (Huang et al., 2009). Agbanyeghị, nke a apụtaghị na synapses emepụtara apụọla ọzọ. Ọ nwekwara ike ịpụta na synapses emebere nkịtị ka agbachighị ọnụ site na ntinye synapti nke (GluA2-enweghị) AMPAR. Nke a nwere ike ịbụ otu n'ime usoro dị n'azụ nkwuputa elu cell nke ngalaba AMPAR yana mmụba AMPAR/NMDAR na neurons NAc shei mgbe ọ nwesịrị ogologo oge. Ya mere, mgbanwe ndị a hụrụ na nha AMPAR/NMDAR na mgbanwe ndị a hụrụ na ọnụọgụ synapses dị jụụ nwere ike ịga n'aka. Ọzọkwa, ọgbọ nke synapses nkịtị nwere ike ịkwado plasticity synapti na-esote.

Mkpa omume nke mbelata na oke AMPAR/NMDAR n'oge mwepụta mbụ amabeghị. Atụpụtala na ịda mbà n'obi synapti nke ọgwụ na-akpata nwere ike ime ka akwara NAc shea ghara inwe mmetụta na-emetụta ihe mkpali na-akwụghachi ụgwọ eke, nke nwere ike ibute mmetụta nke anhedonia na dysphoria (Van den Oever et al., 2012). Nke a nwere ike ịbawanye agụụ ọgwụ. A na-eche na nsonaazụ omume nke ịda mbà n'obi synapti na-esochi mkpugheghachi otu ọgwụ bụ nnukwu ngosipụta nke mmetụta omume (Brebner et al., 2005). Na-egbochi ntinye nke ịda mbà n'obi nke synapti site na intra-NAc infusion nke akpụkpọ anụ peptide permeable nke na-akpaghasị endocytosis nke GluA2 gbochiri ịba ụba ọrụ locomotor nke amphetamine re-exposure.

Ike nke nta nke nta nke mgbasa ozi AMPAR n'oge ịwepụ ogologo oge nwere ike mebie "mmụba nke agụụ ọgwụ ọjọọ", ihe omume na-akpali agụụ mmekọahụ na ịchọ ọgwụ na-abawanye nke ọma n'ime ọnwa mbụ mgbe ọ kwụsịrị ọgwụ ọjọọ (Grimm et al., 2001). Ike nke mgbasa ozi AMPAR na-eme ka nzaghachi nke NAc MSNS na atụmatụ metụtara ọgwụ, na-eduga n'ọchịchọ ọgwụ na-achọsi ike. Ịchọ cocaine na-akpata na-achọ mgbe ogologo oge na-ewepụ na nchịkwa onwe onye cocaine belatara site n'itinye onye na-emechi nhọrọ nke GluA2-enweghị AMPAR n'ime NAc (Conrad et al., 2008). Ọzọkwa, ntinye nke GluA2-enweghị AMPAR na amygdala-to-NAc synapses site na. na vivo mkpali optogenetic mgbe mwepu ogologo oge belatara nnabata nke agụụ cocaine (Lee et al., 2013). Mmetụta nke ime ime a bụ ịgbachi nkịtị nke ụfọdụ synapses na-agbachi nkịtị, na-atụ aro na ntozu oke nke synapses na-agbachi nkịtị na-enyekwa aka na ntinye nke agụụ cocaine.

Mgbanwe synapti nke ọgwụ a kọwara na NAc duziri Bellone na Lüscher (2012na Dong na Nestler (2014) iji kwupụta echiche nke rejuvenation nke mgbasa ozi synaptik n'oge ịṅụ ọgwụ cocaine, na-emepụta ụdị synapses nke na-ejikọta ya na mmalite ụbụrụ ụbụrụ (Bellone na Lüscher, 2012; Dong na Nestler, 2014). Ọmụmaatụ bụ ọgbọ nke synapses gbachiri nkịtị yana ntinye synapti nke GluA2 enweghị AMPAR. Ngosipụta na cocaine na-emepeghachi oge dị oke egwu nke mmepe synapse na usoro mesocorticolimbic. Synapses ndị na-eto eto nwere ikike dị elu nke ịme mgbanwe plastik dabere na ahụmahụ na-adịte aka. A na-eche na nke a na-akọwa otú ọgwụ nwere ike isi nweta mgbanwe rọba siri ike na nke na-adịte aka, na-eduga n'icheta ihe metụtara ọgwụ siri ike ma dịgidere (Dong na Nestler, 2014). Echiche mmeghari ahụ gbatịkwara na mgbanwe synapti na VTA, dị ka mweghachi nke GluN3A nwere NMDAR. Eziokwu ahụ bụ na synapses ndị na-eto eto nwere ikike dị elu iji nweta mgbanwe mgbanwe plastik na-adabere na ahụmahụ nwere ike ịkọwa ihe mere ndị na-eto eto ji enwe ike ịṅụ ọgwụ ọjọọ.

Plastic synapti Glutamatergic abụghị naanị n'oge mkpughe ọgwụ na mwepụ. Ọ na-apụtakwa n'oge nlọghachi azụ na ịchọ ọgwụ ọjọọ. Ngosipụta nke ihe jikọrọ cocaine na enweghị cocaine ka achọpụtara na ọ na-eme ka mmụba ngwa ngwa na nha spine dendritic na nha AMPAR / NMDAR na isi NAc nke oke nwere akụkọ ihe mere eme nke nchịkwa onwe onye cocaine (Gipson et al. , 2013a). Mmụba ndị a adịlarị 15 min mgbe ngosipụta nke ihe metụtara cocaine na mmụba nke AMPAR / NMDAR na dayameta isi azụ azụ na 15 min nwere njikọ chiri anya na ike ịchọ ọgwụ. Nke a na-egosi na ike synaptik na-ebute ngwa ngwa na NAc isi MSN nwere ike ịbụ usoro na-ebute nlọghachi azụ. Ka awa abụọ gachara ibido nkwụghachi azụ azụ, nha spine dendritic na oke AMPAR/NMDAR alaghachila n'ọkwa nlọghachi azụ. Arụ ọrụ na prelimbic cortex (PL), mpaghara nke medial PFC (mPFC) nke na-eziga amụma glutamatergic na isi NAc, gosipụtara na ọ na-etinye aka na ya, ebe ọ bụ na microinjection nke GABAR agonists n'ime PL gbochiri ma mgbanwe synapti na-akpata. ịchọ ọgwụ ọjọọ (Gipson et al., 2013a). Ma arụrụ ọrụ nke glutamatergic PL-to-NAc synapses zuru oke iji kpalite nlọghachi azụ n'ezie, ma ọ bụ na mgbanwe synapti kpatara ọ dị mkpa yana maka nlọghachi azụ ka ga-ekpebisi ike. Otú ọ dị, nnyocha e mere n'oge na-adịbeghị anya na-arụrịta ụka maka njikọ dị n'etiti cocaine na-akpata plasticity nke glutamatergic mPFC-to-NAc synapses na nlọghachi azụ (Pascoli et al., 2014).

Mmetụta nke ọrụ na-akpata cue na glutamatergic PL-to-NAc synapses na-eme ka ọ dịkwuo mma site na mbelata ọkwa basal extracellular glutamate na NAc jikọtara ya na iwepụ ọgwụ na-eri ahụ (Gipson et al., 2014). A na-ebelata ọkwa glutamate nke basal na NAc mgbe ma cocaine na-adịghị agbanwe agbanwe na ikpughe nicotine n'ihi arụrụ arụ ọrụ nke glial cystine-glutamate Exchanger, nke na-ebuga glutamate na oghere extracellular (Kalivas, 2009). Nke a na-ebute mbelata ụda glutamate na presynaptic inhibitory mGluR2 na mGluR3 ndị na-anabata ya, nke na-ebelata mgbochi nke ntọhapụ glutamate presynaptic (Gipson et al., 2014). Nke a na-eduga na ntọhapụ synaptik nke glutamate na-azaghachi na atụmatụ metụtara ọgwụ. Ọzọkwa, a naghị ewepụ glutamate a tọhapụrụ nke ọma na synapse, n'ihi na okwu nke glial glutamate transporter 1 (GLT-1), nke na-eme ka glutamate na-eri nri, na-ebelata mgbe ikpughe ọgwụ (Knackstedt et al., 2010; Shen et al., 2014). Ya mere, akara ndị metụtara ọgwụ na-ebute oke glutamate na NAc glutamatergic synapses, nke nwere ike ịkọwa ihe kpatara njirimara ndị a nwere ike inwe mmetụta omume siri ike.

Na mgbakwunye na ịgbanwe ike synapti ozugbo na NAc, a na-echekwa na ọgwụ ọjọọ eme ihe ga-agbanwe ikike NAc synapses iji nweta plastik synapti na-esote. Ejikọtara ọgwụ ọjọọ riri ahụ na mmebi nke NMDAR dabere na LTP na LTD na glutamatergic synapses na isi NAc (Martin et al., 2006; Moussawi et al., 2009; Kasanetz et al., 2010). LTD nwere nsogbu na isi NAc, mana ọ bụghị na shea NAc, mgbe ụbọchị iri abụọ na otu nke abstinence na oke oke nwere cocaine ji aka ya (Martin et al., 2006). Mmebi sitere na ọgwụ ọjọọ na synapti plasticity nwere ike inye aka na-agbanwe agbanwe, omume mmanye nke bụ njirimara riri ahụ ma nwee ike ịkọwa ịṅụ ọgwụ ọjọọ n'agbanyeghị nsonaazụ ahụike na-adịghị mma na ụmụ mmadụ. Mkparịta ụka NMDAR na-adabere na LTD na-adịghị mma n'ihe gbasara ịṅụ ọgwụ ike cocaine ka e mesiri ike site na nchọpụta na ọ bụ naanị oke cocaine na-ejide onwe ya nke mepụtara àgwà ndị dị ka ịṅụ ọgwụ ọjọọ gosipụtara LTD na-adịghị agwụ agwụ, ebe a na-enweta LTD n'ime anụmanụ ndị nọgidere na-eji ọgwụ ọjọọ eme ihe (Kasanetz). et al., 2010). Achọpụtara nsonaazụ yiri nke ahụ mgbe nchịkwa ethanol nke onwe ya gasịrị. NMDAR dabere LTD nwere mmerụ ahụ nke ukwuu mgbe ọ nwesịrị ogologo oge na ụmụ oke nwere mmetụta ethanol, mana ọ bụghị n'ime ụmụ oke a na-agwọ ethanol nke na-etoliteghị mmegharị omume a (Abrahao et al., 2013). D-serine, onye na-emekọ ihe ọnụ nke NMDAR, nwere ike ịrụ ọrụ na mmerụ ahụ na-akpata ọgwụ na NMDAR-based synaptic plasticity (D'Ascenzo et al., 2014). D-serine dị mkpa maka NMDAR na-adabere na LTP na LTD na NAc isi na D-serine ọkwa na-ebelata na NAc isi nke oke oke cocaine (Curcio et al., 2013). N'ime mpekere sitere na oke ndị a na-agwọ cocaine, mmịnye na D-serine weghachiri eweghachi LTP na ntinye LTD. Ya mere, ụkọ cocaine kpatara na NMDAR na-adabere na synaptic plasticity na NAc bụ n'ihi na ọ dịkarịa ala akụkụ ụfọdụ, iji belata ọkwa D-serine.

Dị ka ọ dị na VTA, e nwere ụfọdụ ihe àmà na-egosi na ọ bụghị nanị na ọgwụ ọjọọ na-akpata mgbanwe synaptik zuru ụwa ọnụ na NAc, kamakwa ọ nwere ike imetụta ụdị dị iche iche nke MSN (Wolf na Ferrario, 2010; Creed na Lüscher, 2013). A na-eche na ike synaptik na shei NAc nke na-etolite n'oge nkwụsị ọgwụ na-eme nhọrọ na synapses na D1-receptor-na-egosipụta MSN, ọ bụghị na synapses na D2-receptor-na-egosipụta MSNs (Pascoli et al., 2012). N'oge na-adịbeghị anya, achọpụtara na ike synapti a na synapses na D1-receptor-na-egosipụta MSN dabere na nhazi nke D1R/GluN1 complexes (Cahill et al., 2014). Na-egbochi njikọ D1R/GluN1, ka ị na-echekwa D1R n'otu n'otu na nrịbama dabere na NMDAR, gbochiri ọrụ ERK, nke achọrọ maka ike synapti.

Plastic synapti dị na etiti prefrontal cortex

Ebumnuche ọzọ nke amụma DA sitere na VTA bụ medial prefrontal cortex (mPFC). Neurons pyramidal nke mPFC na-enweta amụma glutamatergic site n'ọtụtụ mpaghara ụbụrụ dị iche iche, gụnyere nucleus basolateral nke amygdala (BLA), ma ziga amụma glutamatergic na VTA, NAc na laghachi na BLA (Gabbott et al., 2005; Nzughari na Nri, 2007; Van den Oever et al., 2010). Ejikọtara ihe riri ahụ na mbelata ọrụ neuronal PFC basal, ma ọ bụ “hypofrontality” (Volkow et al., 2003), nke nwekwara ike ịhụ na oke mgbe nchịkwa cocaine ugboro ugboro (Sun na Rebec, 2006). Enwere ike kewaa mPFC n'ime azụ azụ (gụnyere PL) yana akụkụ ventral (gụnyere cortex infralimbic) nwere njirimara anatomical na arụ ọrụ dị iche iche (Van den Oever et al., 2012). Anatomically, a na-eche na mPFC dorsal na-ebutekarị NAc isi, ebe ventral mPFC na-eziga amụma na shei NAc (Heidbreder na Groenewegen, 2003). A na-echekwa na dorsal na ventral mPFC na-arụ ọrụ dị iche iche na riri ahụ. A na-eche na ọrụ dị na dorsal mPFC ga-amalite ịchọ ọgwụ na ọ dị oke mkpa maka nlọghachi azụ na-achọ ọgwụ (Gipson et al., 2013b). N'aka nke ọzọ, ọrụ dị na ventral mPFC nwere ike igbochi nzaghachi ịchọ ọgwụ (Peters et al., 2008; LaLumiere et al., 2012). N'ozuzu, a na-eche na mPFC ga-arụ ọrụ dị mkpa na njikwa omume nlọghachi azụ.

Naanị ọmụmụ ole na ole na-enyocha plasticity synapti nke ọgwụ na mPFC ka emerela. Ya mere, anyị nwere naanị ntakịrị ihe ọmụma gbasara ọrụ synaptic plasticity butere ọgwụ na mPFC. In vitro ọmụmụ egosila na nicotine nwere ike ịbawanye ọnụ ụzọ maka ntinye nke ike na-adabere na oge na-adabere na glutamatergic synapses na mouse mPFC Layer V pyramidal neurons site n'ịkwalite ntinye GABAergic na neurons ndị a (Couey et al., 2007). N'ụzọ dị iche, ụbọchị 5 ka ewepụrụ site na ikpughe cocaine na-adịghị agbanwe agbanwe ugboro ugboro (ịgba ọgwụ asaa kwa ụbọchị), ntinye nke LTP mere ka ọ dị mfe na synapses na-akpali akpali n'elu rat mPFC Layer V pyramidal neurons n'ihi mbelata ntinye GABA (Lu et al., 2010). Nke a bụ ihe na-akpata ụbụrụ neurotrophic (BDNF) na-ebute mbelata ngosipụta elu nke GABA.A ndị na-anabata ya na mPFC, na-eduga na nkwụsị nke mgbochi GABAergic. Ọ bụ ezie na enyochaghị mkpa omume nke plasticity a kwalitere nke ọma, enwere ụfọdụ ihe akaebe na-apụtaghị ìhè na nkwado nke ntinye LTP na mPFC nwere ike itinye aka na nhụta omume mgbe mwepụ cocaine gasịrị (Lu et al., 2010).

N'agbanyeghị mbelata mPFC LTP site na ngwa ngwa nke nicotine, ntinye ike nke synaptic na mPFC na-akwado site na nicotine mwepụ, dị ka cocaine. N'oge na ozugbo na-esote na vivo ọgwụgwọ nicotine, ike glutamatergic synaptic ike belatara na mPFC nke oke ndị nọ n'afọ iri na ụma, ebe LTP a mụbara nke ukwuu na mPFC nke oke oke 5 izu mgbe ha nwetasịrị ọgwụgwọ nicotine n'oge uto (Goriounova na Mansvelder, 2012). Mmetụta bidirectional nke ikpughe nicotine n'oge uto na ike synapti nwere ike bụrụ onye ogbugbo site na mgbanwe bidirectional na ọkwa synapti nke inhibitory metabotropic glutamate receptor 2 (mGluR2). Na-esochi ikpughe nicotine n'oge uto, ọkwa protein nke mGluR2 na mPFC synaptic membranes na-abawanye n'ụbọchị mbụ nke mwepụ, mana belatara izu 5 ka ekpughere nicotine (Counotte et al., 2011). N'iji mGluR2 agonists, enwere ike igbochi nkwalite nicotine nke ike synapti, ebe mGluR2 antagonists kwadoro ike synapti (Goriounova na Mansvelder, 2012).

O yikarịrị ka ọ ga-ebute nkwụsị nke obere oge nke ntinye LTP site na mmụba na-adịru nwa oge na nkwupụta nke nAChR nwere α4 na β2 subunits na mPFC ozugbo ikpughe nicotine n'oge uto, nke bụ usoro n'azụ mmachi GABAergic emelitere nke na-akpata nke a. ngọngọ nke LTP (countte et al., 2012). N'ụzọ na-akpali mmasị, mmụba na nkwupụta nke nAChR nwere α4 na β2 subunits na oke mPFC bụ naanị mgbe mkpughe nicotine n'oge uto, ọ bụghị mgbe ikpughe nicotine n'oge okenye (Counotte et al., 2012). N'otu aka ahụ, ọmụmụ nke Goriounova na Mansvelder (2012) gosipụtara ọdịiche dị n'etiti mmetụta nke nicotine ikpughe n'oge uto na n'oge ntozu. Ikpughe Nicotine n'oge ntozu edugaghị na mgbanwe na-adịgide adịgide na LTP. N'ikwekọ na nke a, ikpughe nicotine na-eto eto, ma ọ bụghị ikpughe nicotine postadolescent, na-eduga n'ịbelata ọrụ nlebara anya na mmụba na omume mkpali 5 izu mgbe ọgwụgwọ na oke (Counotte et al., 2009, 2011). Ngosipụta Nicotine n'oge uto na-ebute mbelata na-adịgide adịgide na ọkwa mGluR2 synapti yana nkwalite ike ogologo oge dabere na oke mPFC nke nwere ike bute mbelata ọgụgụ isi n'oge okenye. N'ozuzu, ọmụmụ ihe ndị a na-egosi na oge uto bụ oge dị egwu nke adịghị ike maka mmetụta nicotine na-adịte aka na PFC.

Mgbe ewepụsịrị ogologo oge, a hụrụ mgbanwe na nkesa subunit glutamate n'ọtụtụ ọmụmụ. Dịka ọmụmaatụ, mmụba nke GluA2/3, GluA4, na GluN2B na mPFC ka akọwara mgbe izu abụọ nke abstinence na nchịkwa onwe onye cocaine (Tang et al., 2004). Agbanyeghị, enweghị mmetụta dị ogologo oge na ngosipụta nke membrane synapti nke glutamate receptor subunits na mPFC ka achọpụtara mgbe nchịkwa onwe nke heroin gasịrị (Van den Oever et al., 2008). Ọ ga-ekwe omume na mgbanwe na nkesa subunit glutamate receptor subunit mgbe mwepu ogologo oge ga-ebilite naanị mgbe ị nwetachara ọgwụ. Ihe ọmụmụ Ben-Shahar et al kwadoro nke a. (2009), onye ọzọ chọtara mmụba GluN2B mgbe izu 2 nke abstinence gasịrị, mana ọ bụ naanị na oke ndị agbatịla ohere ịnweta cocaine kwa ụbọchị (Ben-Shahar et al., 2009).

Ebe a na-eche na mPFC na-arụ ọrụ dị mkpa na nlọghachi azụ na-achọ ọgwụ, a nyochakwara ya ma synaptic plasticity na-eme na mPFC n'oge nlọghachi azụ na-achọ ọgwụ. Nkpugheghachi na njirimara ndị metụtara heroin ka izu 3 nke ịhapụ nchịkwa onwe onye nke heroin kpalitere ịda mbà n'obi ngwa ngwa na mPFC nke oke (Van den Oever et al., 2008). Mwapụta nke akpụkpọ ahụ synapti nke AMPAR subunits GluA2 na GluA3 dị na mPFC belatara, na nkwupụta nke protein clathrin-coat AP2m1, nke na-etinye aka na endocytosis na-adabere na clathrin, mụbara. Nke a na-egosi na mkpugheghachi na atụmatụ metụtara heroin butere clathrin-mediated endocytosis nke GluA2/GluA3 AMPARs. Ọzọkwa, a na-ahụ mbelata AMPAR/NMDAR yana mmụba nrụzi n'ime neurons mPFC pyramidal, na-akwado ọnọdụ endocytosis nke GluA2 nwere AMPAR. N'ime nyocha ndị a, emebeghị nkewa n'etiti mPFC azụ na ventral mPFC. Ya mere, amabeghị ma ịda mbà n'obi synapti na-akpata na-eme na mPFC dum ma ọ bụ naanị n'otu mpaghara. Agbanyeghị, mmetụta omume nke igbochi endocytosis nke GluA2 nwere AMPAR ka enyochara iche maka mpaghara mPFC abụọ. N'ụzọ na-akpali mmasị, igbochi GluA2 endocytosis kpọmkwem na ventral mPFC na-eme ka nlọghachi azụ azụ na heroin na-achọ, ebe na-egbochi GluA2 endocytosis na dorsal mPFC emeghị (Van den Oever et al., 2008). Nke a na-egosi na endocytosis ngwa ngwa nke GluA2 nwere AMPARs yana ịda mbà n'obi synapti na-akpata na ventral mPFC dị oke mkpa maka nlọghachi azụ na-achọ heroin. Nke a dabara n'echiche na ventral mPFC na-egosipụta njikwa mgbochi n'ịchọ ọgwụ. N'ihe niile, enwere ike icheta na ịda mbà n'obi synaptik na-akpata na ventral mPFC na-emebi njikwa mgbochi n'ịchọ ọgwụ, si otú a na-eme ka nlọghachi azụ na ịchọ heroin.

Plastic synapti nke sitere na ọgwụ na ụbụrụ mmadụ

Plastic synapti nke ọgwụ na-akpata na sistemụ mesocorticolimbic rodent na-enye aka na mmepe na nnọgidesi ike nke riri ahụ. Ọgwụ ọjọọ ọ na-ebute plasticity synapti n'ụbụrụ mmadụ n'ezie? Ọmụmụ ihe onyonyo mmadụ egosila na ahụ mmadụ riri ahụ na-agụnye mgbanwe na ọrụ n'otu akụkụ ụbụrụ nke egosipụtara mgbanwe synaptik na ụdị anụmanụ riri ahụ (Van den Oever et al., 2012). Ọ bụ ezie na ọmụmụ ihe ndị a enyochaghị plasticity synapti ozugbo, ha na-egosi na ịṅụ ọgwụ ọjọọ na-akpata mgbanwe na-adịgide adịgide na usoro mesocorticolimbic n'ime mmadụ. Naanị ọmụmụ ole na ole enyochala plasticity nke glutamatergic synapses na ụbụrụ mmadụ, na, n'ihi ya, ihe akaebe nke synapti plasticity nke ọgwụ na-akpata bụ obere. Nnwale, plasticity na-adabere na oge nke ikike moto-evoked (MEPs) nwere ike ịkpata na isiokwu mmadụ site na ijikọ mkpali akwara dị n'akụkụ (PNS, nke yiri mkpali presynaptic) na mkpali magnetik transcranial (TMS) nke cortex moto (Stefan et al. , 2000, 2002; Wolters et al., 2003; De Beaumont et al., 2012; Lu et al., 2012). Ụdị mkpali mmekọ ọnụ (PAS) nwere ike ịkpalite ma LTP-dị ka mmụba na LTD-dị ka mbelata na MEP njupụta, dabere na oge ikwu nke mkpali metụtara (Wolters et al., 2003, 2005; Thabit et al., 2010; De Beaumont et al., 2012; Lu et al., 2012; Conde et al., 2013; Koch et al., 2013). N'ọkwa synapti, a chọpụtara na n'ime ụbụrụ ụbụrụ mmadụ a na-awa ahụ, cortical glutamatergic synapses nwere ike ịmalite ma LTP na LTD n'oge ọ bụ okenye, na nzaghachi nke usoro oge yiri nke a na-eji PAS na isiokwu mmadụ (Testa-Silva et al., 2010, 2014; Verhoog et al., 2013). Plasticity nke synapses nke mmadụ toro eto dabere na postsynapti NMDARs na ọwa calcium voltaji gated ụdị L. Grundey et al. (2012) jiri PAS mee ihe na isiokwu mmadụ wee chọpụta na n'oge nicotine na-ewepụ, LTP-dị ka synaptic plasticity nke PAS mere ka a kwụsịrị na ndị na-ese anwụrụ, ma na enwere ike ịzọpụta ya site na nchịkwa nke nicotine patch (Grundey et al., 2012). Nke a na-egosi na usoro synapti plasticity nke ọgwụ na-akpata nwekwara ike ịrụ ọrụ na ụbụrụ mmadụ. N'ụzọ doro anya, a na-achọkwu ọmụmụ ihe gbasara ihe gbasara mmadụ na n'anụ ahụ dị ndụ nke ụbụrụ mmadụ na-awa ahụ iji chọpụta na mgbanwe synapti nke ọgwụ na-akpata nke a na-ahụ na òké na-ekerekwa òkè n'ụbụrụ mmadụ. Enweelarị ihe ịga nke ọma ụfọdụ n'agbanyeghị na ọnwụnwa na ndị na-eri ahụ mmadụ maka ọgwụgwọ sitere n'ike mmụọ nsọ nyocha, dị ka anyị ga-atụle n'okpuru ebe a, na-akwado echiche na mgbanwe synaptik nke ọgwụ na-akpata na nsonaazụ omume ha dị mkpa n'ezie maka mmepe nke ọgwụgwọ riri ahụ.

Ebumnuche ọhụrụ maka usoro ọgwụgwọ nwere ike ime maka ahụ ahụ riri ahụ

Plastic synapti nke ọgwụ butere ọ nwere ike bụrụ ebumnuche maka ọgwụgwọ ndị mmadụ riri ahụ? Anyị ga-atụle ụfọdụ echiche dabere na nyocha riri ahụ òké ihe kpatara plasticity nwere ike na-enye ebumnuche na-ekwe nkwa. Ebe ọ bụ na plasticity synapti nke ọgwụ na-akpata na VTA na-anọchite anya nzọụkwụ mbụ na mgbanwe mgbanwe synaptik n'oge usoro mesocorticolimbic, ntinye aka na ọkwa nke VTA nwere ike igbochi mgbanwe synapti na mpaghara ụbụrụ ụbụrụ dị ka NAc. N'ime anụ ọhịa, enwere ike gbanwee synaptic plasticity nke cocaine na VTA site na ịgbalite ndị na-anabata mGluR1 (Bellone na Lüscher, 2006). Mkpali nke ndị na-anabata mGluR1 na-emepụta ụdị nke mGluR-based LTD, nke mejupụtara nnọchi nke AMPAR na-enweghị GluA2 nwere obere omume GluA2 nwere AMPAR (Mameli et al., 2007). Nke a na-eme ka nnyefe synapti na-edozi. Ọzọkwa, ụdị mGluR-based LTD na-atụgharịkwa redistribution nke cocaine kpatara nke NMDAR (Yuan et al., 2013). Ịhọrọ igbochi synaptic plasticity na VTA zuru ezu iji gbochie synapti plasticity na-esote na NAc na imebi cocaine na-akpata na-achọ mgbe ogologo oge na-ewepụ na ụmụ oke (Mameli et al., 2009), na-atụ aro na atụmatụ a nwere ike ịdị irè n'ịgwọ ọgwụ riri ahụ na ụbụrụ òké. Na NAc, mGluR1 ezigbo modulators nwekwara ike gbanwee plasticity synapti nke ọgwụ na-akpata nke a na-ahụ anya mgbe ọ gbasịrị ogologo oge (Wolf na Tseng, 2012). Ya mere, mGluR1s nwere ike ọ bụghị naanị na enwere ike ịgwọ ọrịa mmalite nke riri ahụ, kama ọ nwekwara ike ime n'oge ikpeazụ nke ọrịa ahụ ma mee ka agụụ ọgwụ ọjọọ kwụsị. Ma mGluR1 ịgbalite na-ebelata ịṅụ ọgwụ ọjọọ n'ezie, agụụ ọgwụ na nlọghachi azụ na òké ka chọrọ nyocha. Ọzọkwa, ma mGluR1 ịgbalite na-emezi ike synapti na VTA na-esochi plasticity synapti nke ọgwụ ọjọọ ndị ọzọ kpatara karịa cocaine amabeghị.

Ebumnuche ọzọ na-ekwe nkwa bụ ọwa ion acid-sensing 1A (ASIC1A), nke na-egbochi cocaine-evoked synaptic plasticity na NAc (Kreple et al., 2014). Ọrụ ASIC1A na-ebelatakwa omume metụtara riri ahụ. Nkwuwa okwu ASIC1A na oke NAc belatara nchịkwa onwe onye cocaine ka mmebi nke ASIC1A mụbara ma morphine-CPP na cocaine-CPP na ụmụ oke (Kreple et al., 2014). Ịkwalite ọrụ ASIC1A nwere ike ịba uru na ọgwụgwọ riri ahụ. A na-eche na ọrụ ASIC1A ga-ebelata site na enzyme carbonic anhydrase IV (CA-IV), nke nwere ọrụ na nhazi nke ntinye pH extracellular na ụbụrụ (Kreple et al., 2014). Ya mere, ogige ndị dị ka CA-IV inhibitor acetazolamide nke na-eme ka ọrụ ASIC1A dịkwuo mma, nwere ike ịbụ ụzọ na-ekwe nkwa ịgbaso.

Usoro dị iche nke nwere ike ịba uru n'ịgwọ ọrịa riri ahụ bụ ịzọpụta ụkọ ọgwụ na-akpata na NMDAR na-adabere na synaptic plasticity na NAc, nke na-enye aka na-adịghị agbanwe agbanwe, àgwà mgbagwoju anya nke riri ahụ (D'Ascenzo et al., 2014). Ebe ọ bụ na mpe mpe mpe mpe mpe mpe mpe akwa synaptic synapti nke NMDAR na NAc na-eche na ọ dịkarịa ala akụkụ ụfọdụ n'ihi belata ọkwa D-serine, ikwado akara ngosi D-serine nwere ike ịnwe nkwa maka ọgwụgwọ ọgwụ riri ahụ. Dịka ọmụmaatụ, enwere ike iweghachi ọkwa D-serine site na nchịkwa nke onye na-egbochi enzyme D-amino acid oxidase, nke na-eweda D-serine (D'Ascenzo et al., 2014). Ka ọ dị ugbu a, a na-amụ ọrụ D-serine naanị n'ihe gbasara ọgwụ riri ahụ. A maghị ma D-serine ọ na-etinyekwa aka na ụdị ọgwụ ọjọọ ndị ọzọ riri ahụ.

Ọtụtụ ọgwụgwọ riri ahụ nwere oke ihe ịga nke ọma n'ihi oke nlọghachi azụ. Usoro ọgwụgwọ na-elekwasị anya n'ibelata ọnụego nlọghachi azụ ga-abụ ihe na-ekwe nkwa. N'inye ọrụ mPFC n'ịchịkwa omume nlọghachi azụ, usoro ọgwụgwọ ọhụrụ nwere ike iji belata ọrụ na mPFC dorsal ma ọ bụ iji kwalite mgbasa ozi glutamatergic na ventral mPFC. Karịsịa, ndị ọrụ na-egbochi endocytosis nke GluA2 nwere AMPAR nwere ike ịba uru iji gbochie nlọghachi azụ. Emere nke a na oke mPFC jiri TAT peptide, TAT-GluR2 (Van den Oever et al., 2008), nke gbochiri GluA2-nwere AMPAR endocytosis na mbelata heroin na-akpata achọ na oke ndị a.

Kama ibelata ọrụ na dorsal mPFC, ụzọ ọzọ maka igbochi nlọghachi azụ nwere ike ịbụ ibelata mmetụta nke ọrụ a na glutamatergic mPFC-to-NAc synapses na NAc. N'oge mwepu na ọgwụ na-eri ahụ, a na-ebelata ọkwa glutamate extracellular na NAc, nke na-eme ka ọnụọgụ glutamate ewepụtara na mPFC-to-NAc synapses mgbe ekpughere ya na atụmatụ metụtara ọgwụ (Gipson et al., 2014). Ọzọkwa, mbelata ọkwa GLT-1 na-ebelata nnabata glutamate site na synapse. Iweghachi ọkwa GLT-1 na extracellular glutamate nwere ike ịbụ ụzọ iji gbochie nlọghachi azụ na-akpata. Otu n'ime ogige na-eweghachi ọkwa GLT-1 na extracellular glutamate na NAc bụ antioxidant N-acetylcysteine ​​​​(NAC; Gipson et al., 2014). A nwalela ọgwụgwọ NAC na ndị na-eri ahụ mmadụ, wee chọpụta na ọ na-ebelata agụụ ọgwụ ọjọọ na iji cocaine (LaRowe et al., 2007; Mardikian et al., 2007).

Nkọwa na ntụziaka n'ọdịnihu

Mgbanwe synapti nke ọgwụ na-akpata na-enye aka na mmepe na nnọgidesi ike nke ịṅụ ọgwụ ọjọọ. Ọ bụ ezie na ihe ọmụma anyị banyere plasticity synapti nke ọgwụ na-akpata adịghị ezu oke, foto na-apụta na nke glutamatergic synaptic plasticity na mpaghara mesocorticolimbic na-arụ ọrụ dị mkpa na ọgwụ riri ahụ (Ọnọdụ). (Figure1) .1). Na mbido, ikpughe ọgwụ na-eri ahụ na-ebute mgbanwe synapti na VTA. Na VTA DA neurons, mkpughe ọgwụ na-ebute ntinye synapti nke omume dị elu GluA2 enweghị AMPAR maka mgbanwe maka omume GluA2 nwere AMPAR dị ala. Ike synapti nke ọgwụ a na-ebute na VTA na-emesị kpalite mgbanwe synapti na mpaghara mgbada nke sistemu mesocorticolimbic (dị ka NAc, PFC, na amygdala) na mkpughe ọgwụ ọzọ. Mgbanwe ndị a na-eme synapti ahụ na-edozi ọtụtụ n'ime mgbaàmà omume nke na-egosipụta riri ahụ. Mbelata AMPAR/NMDAR dị na NAc n'oge mwepụta mbụ nwere ike mebie mmetụta nke ịchọ ọgwụ ahụ iji nwee obi ụtọ, site n'ime ka neurons ghara ịma ihe mkpali na-akwụghachi ụgwọ eke. Ike nke nta nke nta nke nta nke nta nke nta nke nta nke nta nke nta nke nta nke nta nke nta nke nta nke nta nke nta nke nta nke nta nke synapses, na mbelata basal extracellular glutamate na NAc niile na-edozi okwu nke ntinye nke agụụ na-akpali akpali, site n'ịkwalite nzaghachi nke NAc MSN na atụmatụ metụtara ọgwụ. Ọmụmụ ihe n'ọdịnihu nke a na-enyocha mgbanwe synaptik (na nsonaazụ omume ha) na ma NAc isi na shei dị mkpa iji kesaa ọrụ nke NAc isi na shei na ụdị ọrụ a. Mgbanwe synapti nke ọgwụ na-eme na PFC na-ekere òkè dị mkpa na nlọghachi azụ. Mmetụta ịda mbà n'obi nke synaptik ngwa ngwa na ventral mPFC na-emebi mgbochi nzaghachi na ikpughe akara ndị metụtara ọgwụ, si otú a na-emezi nlọghachi na ịchọ ọgwụ. Neuroadaptations sitere na ọgwụ ọjọọ na mPFC dorsal n'aka nke ọzọ na-eme ihe iji kwalite mmepụta ihe na-akpali akpali site na mpaghara a na isi NAc, nke na-akpali ịchọ ọgwụ.

Nyocha 1   

Ihe nlereanya na-arụ ọrụ nke synaptic plasticity na-ebute ọgwụ na usoro mesocorticolimbic na ọgwụ riri ahụ.. Atụmatụ dị mfe nke mpaghara ụbụrụ mesocorticolimbic mara na plasticity sitere na ọgwụ na-emetụta ya, mgbanwe synapti dị mkpa. ...

Achọkwuru nyocha iji nyochaa na ịgbatị ụdị ọrụ a, ebe ọ bụ na mgbanwe synapti nke ọgwụ ndị na-eri ahụ na-ebute dị ọtụtụ ma dị mgbagwoju anya. Ọtụtụ ajụjụ dị mkpa ka azaghị. Dịka ọmụmaatụ, a na-amụkarị plasticity synapti ọgwụ ọgwụ na VTA na NAc, mana ihe ọmụma anyị gbasara mgbanwe synapti na mPFC na nsonaazụ omume ha ka nwere oke. Tụkwasị na nke ahụ, ihe neuroadaptations ọgwụ na-eme na mpaghara ụbụrụ ndị ọzọ na-ekere òkè na ịṅụ ọgwụ ọjọọ, dị ka amygdala na habenula (Maroteaux na Mameli, 2012; Van den Oever et al., 2012; Lecca et al., 2014), ebe plasticity nwekwara ike ịpụta nke ọma? Ọtụtụ n'ime ọmụmụ ihe ndị a tụlere na nyocha a, nyochara kpọmkwem plasticity synapti nke cocaine kpatara. Nchọpụta a ọ na-emetụta ọgwụ ndị ọzọ eji eme ihe? Nke a dị mkpa karịsịa ebe ọ bụ na ụdị ọgwụ dị iche iche nwere ike inwe mmetụta dị iche iche na mgbasa ozi synapti (Wolf na Ferrario, 2010). Ihe ọzọ a na-edozibeghị bụ ntọala akwara ozi nke ndịiche dị n'otu n'otu na adịghị ike na ịṅụ ọgwụ ọjọọ. Nnyocha na-atụnyere mmetụta nke ọgwụ na-eri ahụ na anụmanụ ndị na-azụlite omume riri ahụ na mmetụta nke ọgwụ na-eri ahụ na anụmanụ ndị na-enweghị ike inye aka n'ịchọta njikọ synaptic nke adịghị ike riri ahụ (Kasanetz et al., 2010; Abrahao et al., 2013). N'ikpeazụ, ọgwụ ọjọọ nwere ike imetụta ọnụ ọgụgụ dị iche iche nke neurons n'ime mpaghara ụbụrụ kpọmkwem (Wolf na Ferrario, 2010; Creed na Lüscher, 2013). Ọ ga-abụ ihe na-atọ ụtọ ịmụta ka nzaghachi dị iche iche nke ọnụ ọgụgụ dị nta nke neurons maka ọgwụ na ihe metụtara ọgwụ na mpaghara mesocorticolimbic dị iche iche na-ebute akụkụ dị iche iche nke ahụ riri ahụ.

Nkwupụta mgbasa ozi mkparịta ụka

Ndị na-ede akwụkwọ na-ekwupụta na e mere nchọpụta ahụ na enweghi mmekọrịta ọ bụla ma ọ bụ ego ma ọ bụ ego nke a pụrụ iwere dị ka ihe nwere ike ịmasị.

References

  1. Abrahao KP, Ariwodola OJ, Butler TR, Rau AR, Skelly MJ, Carter E., et al. . (2013). Mmetụta Locomotor na ethanol na-emebi NMDA receptor synaptic plasticity na nucleus accumbens ma na-abawanye nchịkwa ethanol. J. Neurosci. 33, 4834–4842. 10.1523/JNEUROSCI.5839-11.2013 [PMC free article] [PubMed] [Cross Ref]
  2. Òtù Na-ahụ Maka Ọrịa Uche nke America (2013). Akwụkwọ ntuziaka nchọpụta na ọnụ ọgụgụ nke nsogbu uche: DSM-V. 5th Edn., Arlington, VA: Mbipụta Ọrịa Uche America.
  3. Argilli E., Sibley DR, Malenka RC, England PM, Bonci A. (2008). Mechanism na usoro oge nke cocaine na-ebute ike ogologo oge na mpaghara Ventral Tegmental. J. Neurosci. 28, 9092–9100. 10.1523/JNEUROSCI.1001-08.2008 [PMC free article] [PubMed] [Cross Ref]
  4. Bellone C., Lüscher C. (2006). Cocaine kpalitere nkesa nnabata AMPA na vivo site na mGluR dabere na ịda mbà n'obi ogologo oge. Mba. Neurosci. 9, 636–641 . 10.1038/nn1682 [PubMed] [Cross Ref]
  5. Bellone C., Lüscher C. (2012). Plasticity nke ọgwụ wepụrụ: ọgwụ ndị na-eri ahụ ọ na-emepeghachi oge dị oke egwu nke mmepe synapti nke postnatal? N'ihu. Mol. Neurosci. 5:75 . 10.3389/fnmol.2012.00075 [PMC free article] [PubMed] [Cross Ref]
  6. Ben-Shahar O., Obara I., Ary AW, Ma N., Mangiardi MA, Medina RL, et al. . (2009). Nweta nsonaazụ cocaine kwa ụbọchị na mgbanwe dị iche iche na Homer 1b/c na nkwupụta subunit NMDA n'ime medial prefrontal cortex. Nkọwa nke 63, 598-609. 10.1002/ syn.20640 [PMC free article] [PubMed] [Cross Ref]
  7. Bocklisch C., Pascoli V., Wong JCY, Ụlọ DRC, Yvon C., de Roo M., et al. . (2013). Cocaine na-egbochi neurons dopamine site na ike nke nnyefe GABA na mpaghara ventral tegmental. Sayensị 341, 1521–1525. 10.1126/sayensị.1237059 [PubMed] [Cross Ref]
  8. Borgland SL, Malenka RC, Bonci A. (2004). Nnukwu ike na-adịghị ala ala cocaine kpatara ike synapti na mpaghara ventral tegmental: electrophysiological na omume na-ejikọta na oke n'otu n'otu. J. Neurosci. 24, 7482–7490. 10.1523/jneurosci.1312-04.2004PubMed] [Cross Ref]
  9. Boudreau AC, Wolf ME (2005). Mmetụta omume omume na cocaine jikọtara ọnụ ọgụgụ elu AMPA ndị na-anabata ihe na nucleus accumbens. J. Neurosci. 25, 9144–9151. 10.1523/jneurosci.2252-05.2005 [PubMed] [Cross Ref]
  10. Brebner K., Wong TP, Liu L., Liu Y., Campsall P., Grey S., et al. . (2005). Nucleus na-akwakọba ịda mbà n'obi ogologo oge na ngosipụta nke mmetụta omume. Sayensị 310, 1340–1343. 10.1126/sayensị.1116894 [PubMed] [Cross Ref]
  11. Cahill E., Pascoli V., Trifilieff P., Savoldi D., Kappès V., Luscher C., et al. . (2014). D1R / GluN1 ogige dị na striatum na-ejikọta dopamine na akara glutamate iji chịkwaa plasticity synapti na nzaghachi cocaine kpatara. Mol. Isi mgbaka 19, 1295–1304. 10.1038/mp.2014.73 [PMC free article] [PubMed] [Cross Ref]
  12. Chen BT, Bowers MS, Martin M., Hopf FW, Guillory AM, Carelli RM, et al. . (2008). Cocaine mana ọ bụghị ụgwọ ọrụ okike nke nchịkwa onwe onye ma ọ bụ infusion cocaine na-emepụta LTP na-adịgide adịgide na VTA. Neuron 59, 288–297. 10.1016/j.neuron.2008.05.024 [PMC free article] [PubMed] [Cross Ref]
  13. Conde V., Vollmann H., Taubert M., Sehm B., Cohen LG, Villringer A., ​​et al. . (2013). Plasticity mmekọrịta oge na-agbanwe agbanwe na ụbụrụ mmadụ site na mmekọrịta interhemispheric. J. Neurophysiol. 109, 2260–2271. 10.1152/jn.01004.2012 [PMC free article] [PubMed] [Cross Ref]
  14. Conrad KL, Tseng KY, Uejima JL, Reimers JM, Heng L.-J., Shaham Y., et al. . (2008). Nhazi nke accumbens GluR2-enweghị AMPA ndị na-anabata ya na-eme ka nnabata nke agụụ cocaine. Ọdịdị 454, 118–121. 10.1038/ ọdịdị06995 [PMC free article] [PubMed] [Cross Ref]
  15. Cornish JL, Kalivas PW (2000). Mgbasa Glutamate na nucleus na-eme ka ọ laghachi azụ na ịṅụ ọgwụ cocaine. J. Neurosci. 20, 1–5. [PubMed]
  16. Couey JJ, Meredith RM, Spijker S., Poorthuis RB, Smit AB, Brussaard AB, et al. . (2007). Omume netwọkụ ekesa site na nicotine na-abawanye ọnụ ụzọ maka plasticity na-adabere na oge na-agba ọsọ na cortex prefrontal. Neuron 54, 73–87. 10.1016/j.neuron.2007.03.006 [PubMed] [Cross Ref]
  17. Countette DS, Goriounova NA, Li KW, Loos M., van der Schors RC, Schetters D., et al. . (2011). Mgbanwe synaptik na-adịgide adịgide na-akpata mbelata nlebara anya nke nicotine kpatara n'oge uto. Mba. Neurosci. 14, 417–419 . 10.1038/nn.2770 [PubMed] [Cross Ref]
  18. Countotte DS, Goriounova NA, Moretti M., Smoluch MT, Irth H., Clementi F., et al. . (2012). Ikpughe nicotine na-eto eto nwa oge na-abawanye nnabata nicotinic nwere mmekọrịta dị elu ma na-agbanwe mgbasa ozi synapti na-egbochi oke na oke medial prefrontal cortex. FASEB J. 26, 1810–1820. 10.1096/fj.11-198994 [PMC free article] [PubMed] [Cross Ref]
  19. Countette DS, Spijker S., Van de Burgwal LH, Hogenboom F., Schoffelmeer ANM, De Vries TJ, et al. . (2009). Mwepu ọgụgụ isi na-adịte aka na-esite na ikpughe nicotine na-eto eto na oke. Neuropsychopharmacology 34, 299-306. 10.1038/npp.2008.96 [PubMed] [Cross Ref]
  20. Creed MC, Lüscher C. (2013). Ọkpụkpụ synaptic ọgwụ ọjọọ na-akpata: karịrị metaplasticity. Curr. Mechie. Neurobiol. 23, 553-558. 10.1016 / j.conb.2013.03.005 [PubMed] [Cross Ref]
  21. Curcio L., Podda MV, Leone L., Piacentini R., Mastrodonato A., Cappelletti P., et al. . (2013). Mbelata ọkwa D-serine dị na nucleus accumbens nke oke ndị a na-agwọ cocaine na-egbochi nnabata nke NMDA dabere na plasticity synapti. Ụbụrụ 136, 1216–1230. 10.1093/ụbụrụ/awt036 [PubMed] [Cross Ref]
  22. D'Ascenzo M., Podda MV, Grassi C. (2014). Ọrụ nke D-serine dị ka co-agonist nke ndị na-anabata NMDA na nucleus accumbens: mkpa maka ịṅụ ọgwụ ọjọọ cocaine. N'ihu. Synapti neurosci. 6:16 . 10.3389/fnsyn.2014.00016 [PMC free article] [PubMed] [Cross Ref]
  23. De Beaumont L., Tremblay S., Poirier J., Lassonde M., Théoret H. (2012). Plasticity bidirectional gbanwere yana mbelata mmụta moto ezoro ezo n'ime ndị egwuregwu nwere mgbagwoju anya. Cereb. Cortex 22, 112–121. 10.1093/cercor/bhr096 [PubMed] [Cross Ref]
  24. Di Chiara G., Imperato A. (1988). Ọgwụ ndị mmadụ na-emegbu na-aka mma na-abawanye mkpokọta synapti dopamine na sistemụ mesolimbic nke oke na-akpụ akpụ. Proc. Natl. Acad. Sci. USA 85, 5274–5278. 10.1073/pnas.85.14.5274 [PMC free article] [PubMed] [Cross Ref]
  25. Dong Y., Nestler EJ (2014). Echiche mmeghari akwara nke cocaine riri ahụ. Trends Pharmacol. Sci. 35, 374–383. 10.1016/j.Tips.2014.05.005 [PMC free article] [PubMed] [Cross Ref]
  26. EMCDDA (2013). Akụkọ banyere ọgwụ ọjọọ nke Europe 2013. Dị na ntanetị na: http://www.emcdda.europa.eu/attachements.cfm/att_213154_EN_TDAT13001ENN1.pdf.
  27. Engblom D., Bilbao A., Sanchis-Segura C., Dahan L., Perreau-Lenz S., Balland B., et al. . (2008). Ndị na-anabata Glutamate na neurons dopamine na-achịkwa nnọgidesi ike nke ịchọ cocaine. Neuron 59, 497–508. 10.1016/j.neuron.2008.07.010 [PubMed] [Cross Ref]
  28. Fitzgerald LW, Ortiz J., Hamedani AG, Nestler EJ (1996). Ọgwụ nke mmegbu na nchekasị na-abawanye nkwupụta nke GluR1 na NMDAR1 glutamate receptor subunits na mpaghara ventral ventral tegmental mpaghara: mmegharị a na-ahụkarị n'etiti ndị ọrụ na-eche echiche. J. Neurosci. 16, 274–282 . [PubMed]
  29. Gabbott PL, Warner TA, Jays PRL, Salway P., Busby SJ (2005). Prefrontal cortex na oke: amụma maka subcortical autonomic, moto na limbic center. J. Comp. Neurol. 492, 145–177 . 10.1002/cne.20738 [PubMed] [Cross Ref]
  30. Gipson CD, Kupchik YM, Kalivas PW (2014). Ngwa ngwa, plastic synapti na-agafe agafe na ahụ riri ahụ. Neuropharmacology 76 (Pt. B), 276-286. 10.1016/j.neuropharm.2013.04.032PMC free article] [PubMed] [Cross Ref]
  31. Gipson CD, Kupchik YM, Shen H., Reissner KJ, Thomas CA, Kalivas PW (2013a). Nlaghachi azụ site na amụma ịkọ cocaine na-adabere na ike synapti na-adị ngwa ngwa. Neuron 77, 867–872. 10.1016/j.neuron.2013.01.005 [PMC free article] [PubMed] [Cross Ref]
  32. Gipson CD, Reissner KJ, Kupchik YM, Smith ACW, Stankeviciute N., Hensley-Simon ME, et al. . (2013b). glutamatergic plasticity na-edozi iweghachite nke ịchọ nicotine. Proc. Natl. Acad. Sci. USA 110, 9124–9129. 10.1073/pnas.1220591110PMC free article] [PubMed] [Cross Ref]
  33. Goriounova NA, Mansvelder HD (2012). Ikpughe Nicotine n'oge uto na-eduga na mgbanwe dị mkpụmkpụ na ogologo oge na plasticity na-adabere na oge na-adabere na oke prefrontal cortex. J. Neurosci. 32, 10484–10493. 10.1523/JNEUROSCI.5502-11.2012 [PMC free article] [PubMed] [Cross Ref]
  34. Grimm JW, Hope BT, Wise RA, Shaham Y. (2001). Neuroadaptation. Mmalite nke agụụ cocaine mgbe ọ kwụsịrị. Ọdịdị 412, 141–142. 10.1038/35084134PMC free article] [PubMed] [Cross Ref]
  35. Groenewegen HJ, Wright CI, Beijer AV, Voorn P. (1999). Nchikota na nkewa nke ntinye na ntinye ventral striatal. Ann. NY Acad. Sci. 877, 49–63. 10.1111/j.1749-6632.1999.tb09260.x [PubMed] [Cross Ref]
  36. Grundey J., Thirugnanasambandam N., Kaminsky K., Drees A., Skwirba AC, Lang N., et al. . (2012). A na-agbanwe Neuroplasticity na ndị na-ese sịga n'okpuru nkwụsị ma na-edozi akụkụ nke nicotine. J. Neurosci. 32, 4156–4162. 10.1523/JNEUROSCI.3660-11.2012 [PubMed] [Cross Ref]
  37. Heidbreder CA, Groenewegen HJ (2003). Ọkpụkpụ na-ahụ maka ụbụrụ a na-ahụ anya na rat: ihe akaebe maka ọdịiche dorso-ventral nke dabeere na njirimara na ọdịdị anatomical. Neurosci. Biobehav. Rev. 27, 555-579. 10.1016 / j.neubiorev.2003.09.003 [PubMed] [Cross Ref]
  38. Hoover W., Vertes R. (2007). Nyocha anatomical nke amụma afferent na medial prefrontal cortex na oke. Structụ ụbụrụ. Ọrụ 212, 149–179 . 10.1007/s00429-007-0150-4PubMed] [Cross Ref]
  39. Huang YH, Lin Y., Mu P., Lee BR, Brown TE, Wayman G., et al. . (2009). Na vivo ahụmahụ cocaine na-emepụta synapses nkịtị. Neuron 63, 40–47. 10.1016/j.neuron.2009.06.007 [PMC free article] [PubMed] [Cross Ref]
  40. Isaac JTR, Ashby MC, McBain CJ (2007). Ọrụ nke ngalaba GluR2 na ọrụ nnabata AMPA na plastik synapti. Neuron 54, 859–871. 10.1016/j.neuron.2007.06.001 [PubMed] [Cross Ref]
  41. Isaac JT, Nicoll RA, Malenka RC (1995). Ihe akaebe maka synapses dị jụụ: ihe ọ pụtara maka okwu LTP. Neuron 15, 427–434. 10.1016/0896-6273(95)90046-2PubMed] [Cross Ref]
  42. Johnson SW, North RA (1992). Opioids na-akpali neurons dopamine site na hyperpolarization nke interneurons mpaghara. J. Neurosci. 12, 483–488. [PubMed]
  43. Kalivas PW (2009). Echiche nkwupụta ụba nke ndị na-eri nri na-abaghị uru. Nat. Mkpu. Neurosci. 10, 561-572. 10.1038 / nrn2515 [PubMed] [Cross Ref]
  44. Kalivas PW, Churchill L., Klitenick MA (1993). Ntụle GABA na enkephalin sitere na nucleus accumbens na ventral pallidum ruo mpaghara ventral tegmental. Neuroscience 57, 1047-1060. 10.1016/0306-4522(93)90048-kPubMed] [Cross Ref]
  45. Kasanetz F., Deroche-Gamonet V., Berson N., Balado E., Lafourcade M., Manzoni O., et al. . (2010). A na-ejikọta mgbanwe na ihe riri ahụ na mmebi na-adịgide adịgide na plastik synaptic. Sayensị 328, 1709-1712. 10.1126/sayensị.1187801 [PubMed] [Cross Ref]
  46. Knackstedt LA, Melendez RI, Kalivas PW (2010). Ceftriaxone na-eweghachi homeostasis glutamate ma gbochie nlọghachi azụ na ịchọ cocaine. Biol. Isi mgbaka 67, 81–84. 10.1016/j.biopsych.2009.07.018 [PMC free article] [PubMed] [Cross Ref]
  47. Koch G., Ponzo V., Di Lorenzo F., Caltagirone C., Veniero D. (2013). Hebbian na mgbochi hebbian spike-oge dabere plasticity nke njikọ cortico-cortical mmadụ. J. Neurosci. 33, 9725–9733. 10.1523/JNEUROSCI.4988-12.2013 [PubMed] [Cross Ref]
  48. Kourrich S., Rothwell PE, Klug JR, Thomas MJ (2007). Ahụmịhe cocaine na-achịkwa plasticity synaptic bidirectional na nucleus accumbens. J. Neurosci. 27, 7921–7928. 10.1523/jneurosci.1859-07.2007 [PubMed] [Cross Ref]
  49. Koya E., Cruz FC, Ator R., Golden SA, Hoffman AF, Lupica CR, et al. . (2012). Synapses gbachiri nkịtị na nucleus na-arụ ọrụ ahọpụtara na-anakọta neurons na-eso mmetụta cocaine. Mba. Neurosci. 15, 1556–1562. 10.1038/nn.3232 [PMC free article] [PubMed] [Cross Ref]
  50. Koya E., Golden SA, Harvey BK, Guez-Barber DH, Berkow A., Simmons DE, et al. . (2009). Nkwụsịtụ ezubere iche nke nucleus na-arụ ọrụ cocaine na-akwakọba neurons na-egbochi nghọta gbasara ọnọdụ. Mba. Neurosci. 12, 1069–1073. 10.1038/nn.2364 [PMC free article] [PubMed] [Cross Ref]
  51. Kreple CJ, Lu Y., Taugher RJ, Schwager-Gutman AL, Du J., Stump M., et al. . (2014). Ọwa ion nke na-ahụta acid na-enye aka na mgbasa ozi synapti ma gbochie plasticity nke cocaine. Mba. Neurosci. 17, 1083–1091. 10.1038/nn.3750 [PMC free article] [PubMed] [Cross Ref]
  52. LaLumiere RT, Smith KC, Kalivas PW (2012). Asọmpi sekit akwara ozi na ịchọ cocaine: ọrụ nke cortex infralimbic na nucleus accumens shei. Euro. J. Neurosci. 35, 614–622. 10.1111/j.1460-9568.2012.07991.x [PMC free article] [PubMed] [Cross Ref]
  53. Lammel S., Ion DI, Roeper J., Malenka RC (2011). Mgbanwe ụda nke dopamine neuron synapses site na mmegharị na-akwụghachi ụgwọ. Neuron 70, 855-862. 10.1016 / j.neuron.2011.03.025 [PMC free article] [PubMed] [Cross Ref]
  54. Lammel S., Lim BK, Malenka RC (2013). Nkwụghachi ụgwọ na ịkpọasị na sistemụ etiti ụbụrụ dopamine dị iche iche. Neuropharmacology 76, 351-359. 10.1016/j.neuropharm.2013.03.019PMC free article] [PubMed] [Cross Ref]
  55. Lammel S., Lim BK, Ran C., Huang KW, Betley MJ, Tye KM, et al. . (2012). Njikwa ntinye aka nke nkwụnye ụgwọ na nkwụsị na mpaghara mmepụta nke ventral. Nature 491, 212-217. 10.1038 / Nature11527 [PMC free article] [PubMed] [Cross Ref]
  56. LaRowe SD, Myrick H., Hedden S., Mardikian PN, Saladin M., McRae A., et al. . (2007). N-Acetylcysteine ​​​​na-ebelata ọchịchọ cocaine? M. J. Isi mgbaka 164, 1115–1117. 10.1176/ajp.2007.164.7.1115 [PubMed] [Cross Ref]
  57. Lecca S., Meye FJ, Mameli M. (2014). Habenula mpụta na ahụ riri ahụ na ịda mbà n'obi: ihe anatomical, synaptik na nyocha omume. Euro. J. Neurosci. 39, 1170–1178. 10.1111/ejn.12480 [PubMed] [Cross Ref]
  58. Lee BR, Ma Y.-Y., Huang YH, Wang X., Otaka M., Ishikawa M., et al. . (2013). Mmụba nke synapses dị jụụ na amụma amygdala-accumbens na-enye aka na ntinye nke agụụ cocaine. Mba. Neurosci. 16, 1644–1651. 10.1038/nn.3533 [PMC free article] [PubMed] [Cross Ref]
  59. Liu Q.-S., Pu L., Poo M.-M. (2005). Ikpughe cocaine ugboro ugboro na vivo na-eme ka ntinye LTP dị na etiti ụbụrụ dopamine neurons. Ọdịdị 437, 1027-1031. 10.1038/ ọdịdị04050 [PMC free article] [PubMed] [Cross Ref]
  60. Lu H., Cheng P.-L., Lim BK, Khoshnevisrad N., Poo M.-M. (2010). BDNF dị elu mgbe mwepu cocaine na-eme ka LTP dị na medial prefrontal cortex site na igbochi mgbochi GABA. Neuron 67, 821–833. 10.1016/j.neuron.2010.08.012 [PMC free article] [PubMed] [Cross Ref]
  61. Lu M.-K., Tsai C.-H., Ziemann U. (2012). Cerebellum na moto cortex jikọtara mkpali mkpali na-ebute bidirectional STDP dị ka plasticity na cortex moto mmadụ. N'ihu. Hum. Neurosci. 6:260. 10.3389/fnhum.2012.00260 [PMC free article] [PubMed] [Cross Ref]
  62. Lüscher C. (2013). Plastic synapti nke ọgwụ kpalitere na-akpata omume riri ahụ. J. Neurosci. 33, 17641–17646. 10.1523/JNEUROSCI.3406-13.2013 [PubMed] [Cross Ref]
  63. Lüscher C., Malenka RC (2011). Plastic synaptic nke ọgwụ na-eme ka ọ bụrụ ọgwụ na-eri ahụ: site na mgbanwe mkpụrụ ndụ na imegharị sekit. Neuron 69, 650–663. 10.1016/j.neuron.2011.01.017 [PMC free article] [PubMed] [Cross Ref]
  64. Luu P., Malenka RC (2008). Ogologo oge na-adabere na spike na sel ventral Tegmental mpaghara dopamine chọrọ PKC. J. Neurophysiol. 100, 533–538. 10.1152/jn.01384.2007 [PMC free article] [PubMed] [Cross Ref]
  65. Mameli M., Balland B., Luján R., Lüscher C. (2007). Njikọ ngwa ngwa na ntinye synapti nke GluR2 maka mGluR-LTD na mpaghara ventral tegmental. Sayensị 317, 530-533. 10.1126/sayensị.1142365 [PubMed] [Cross Ref]
  66. Mameli M., Bellone C., Brown MTC, Lüscher C. (2011). Cocaine na-atụgharị iwu maka plastik synapti nke nnyefe glutamate na mpaghara ventral tegmental. Ndi. Neurosci. 14, 414–416 . 10.1038/nn.2763 [PubMed] [Cross Ref]
  67. Mameli M., Halbout B., Creton C., Engblom D., Parkitna JR, Spanagel R., et al. . (2009). Plastic synapti nke Cocaine kpalitere: nnọgidesi ike na VTA na-akpalite mmegharị na NAc. Mba. Neurosci. 12, 1036–1041. 10.1038/nn.2367 [PubMed] [Cross Ref]
  68. Mansvelder HD, Keath JR, McGehee DS (2002). Usoro synapti na-ebute mmetụta nicotine na-akpata nke mpaghara ụgwọ ọrụ ụbụrụ. Neuron 33, 905–919. 10.1016/s0896-6273(02)00625-6PubMed] [Cross Ref]
  69. Mansvelder HD, McGehee DS (2000). Ike ogologo oge nke ntinye mkpali na ụbụrụ na-akwụghachi mpaghara ụgwọ site na nicotine. Neuron 27, 349–357. 10.1016/s0896-6273(00)00042-8 [PubMed] [Cross Ref]
  70. Mao D., Gallagher K., McGehee DS (2011). Ike Nicotine nke ntinye mkpali na mpaghara ventral tegmental dopamine neurons. J. Neurosci. 31, 6710–6720. 10.1523/JNEUROSCI.5671-10.2011 [PMC free article] [PubMed] [Cross Ref]
  71. Mardikian PN, LaRowe SD, Hedden S., Kalivas PW, Malcolm RJ (2007). Nnwale na-emeghe akara nke N-acetylcysteine ​​​​maka ọgwụgwọ nke ịdabere na cocaine: nchọpụta pilot. Prog. Neuropsychopharmacol. Biol. Isi mgbaka 31, 389–394. 10.1016/j.pnpbp.2006.10.001 [PubMed] [Cross Ref]
  72. Maroteaux M., Mameli M. (2012). Cocaine na-akpalite ntule-kpọmkwem synaptic plasticity nke mpụta habenula neurons. J. Neurosci. 32, 12641–12646. 10.1523/JNEUROSCI.2405-12.2012 [PubMed] [Cross Ref]
  73. Martin M., Chen BT, Hopf FW, Bowers MS, Bonci A. (2006). Ịchịkwa onwe nke Cocaine na-ahọrọ nke ọma kagbuo LTD na isi nke nucleus accumens. Mba. Neurosci. 9, 868–869. 10.1038/nn1713PubMed] [Cross Ref]
  74. Maskos U., Molles BE, Pons S., Besson M., Guiard BP, Guilloux JP, et al. . (2005). Nkwalite nicotine na cognition weghachiri eweghachi site na nkwupụta ezubere iche nke ndị na-anabata nicotinic. Ọdịdị 436, 103–107. 10.1038/ ọdịdị03694 [PubMed] [Cross Ref]
  75. Mato S., Chevaleyre V., Robbe D., Pazos A., Castillo PE, Manzoni OJ (2004). Otu ikpughe in-vivo na delta 9THC na-egbochi endocannabinoid-mediated synapti plasticity. Mba. Neurosci. 7, 585–586 . 10.1038/nn1251 [PubMed] [Cross Ref]
  76. Moussawi K., Pacchioni A., Moran M., Olive MF, Gass JT, Lavin A., et al. . (2009). N-Acetylcysteine ​​​​na-atụgharị metaplasticity sitere na cocaine. Mba. Neurosci. 12, 182–189. 10.1038/nn.2250 [PMC free article] [PubMed] [Cross Ref]
  77. Niehaus JL, Murali M., Kauer JA (2010). Ọgwụ nke mmegbu na nchekasị na-emebi LTP na synapses inhibitory na mpaghara ventral tegmental. Euro. J. Neurosci. 32, 108–117. 10.1111/j.1460-9568.2010.07256.x [PMC free article] [PubMed] [Cross Ref]
  78. Pascoli V., Terrier J., Ndị ọkà mmụta mmụọ, J., Valjent E., O'Connor EC, Lüscher C. (2014). Ụdị dịgasị iche iche nke cocaine na-eme ka plasticity control components of relapse. Nature 509, 459-464. 10.1038 / Nature13257 [PubMed] [Cross Ref]
  79. Pascoli V., Turiault M., Lüscher C. (2012). Mgbanwe nke sycaptic nwere ike ịbanye na ọgwụ cocaine na-ebute omume ngbanwe nke ọgwụ. Nature 481, 71-75. 10.1038 / Nature10709 [PubMed] [Cross Ref]
  80. Peters J., LaLumiere RT, Kalivas PW (2008). Corralxbic prefrontal cortex bụ ọrụ maka igbochi cocaine na-achọ ná mpi emenyụ. J. Neurosci. 28, 6046-6053. 10.1523 / JNEUROSCI.1045-08.2008 [PMC free article] [PubMed] [Cross Ref]
  81. Ping A., Xi J., Prasad BM, Wang MH, Kruzich PJ (2008). Ntụnye nke nucleus na-achịkọta isi na shei GluR1 nwere ndị na-anabata AMPA na AMPA- na cocaine-primed mweghachi nke omume ịchọ cocaine. Brain Res. 1215, 173–182. 10.1016/j.brainres.2008.03.088 [PMC free article] [PubMed] [Cross Ref]
  82. Robinson TE, Kolb B. (2004). Plasticity ihe owuwu jikọtara ya na ikpughe ọgwụ eji eme ihe. Neuropharmacology 47 (Nkwanye 1), 33-46. 10.1016/j.neuropharm.2004.06.025PubMed] [Cross Ref]
  83. Saal D., Dong Y., Bonci A., Malenka RC (2003). Ọgwụ nke mmegbu na nchekasị na-akpalite mmegharị synapti na-emekarị na neurons dopamine. Neuron 37, 577–582. 10.1016/s0896-6273(03)00021-7 [PubMed] [Cross Ref]
  84. Schramm-Sapyta NL, Olsen CM, Winder DG (2006). nchịkwa onwe nke Cocaine na-ebelata nzaghachi mkpali na nucleus mouse accumens shei. Neuropsychopharmacology 31, 1444-1451. 10.1038/sj.npp.1300918PubMed] [Cross Ref]
  85. Schultz W. (1998). Ihe mgbaàmà nke ụgwọ ọrụ nke dopamine neurons. J. Neurophysiol. 80, 1-27. [PubMed]
  86. Shen H.-W., Scofield MD, Boger H., Hensley M., Kalivas PW (2014). Synapti glutamate spillover n'ihi enweghị glutamate nnabata na-eme ka heroin laghachi azụ. J. Neurosci. 34, 5649–5657. 10.1523/JNEUROSCI.4564-13.2014 [PMC free article] [PubMed] [Cross Ref]
  87. Stefan K., Kunesch E., Benecke R., Cohen LG, Classen J. (2002). Usoro nkwalite nke moto mmadụ cortex mkpali na-ebute site na ntinye aka jikọtara ọnụ. J. Physiol. 543, 699–708. 10.1113/jphysiol.2002.023317 [PMC free article] [PubMed] [Cross Ref]
  88. Stefan K., Kunesch E., Cohen LG, Benecke R., Classen J. (2000). Mmalite nke plasticity na cortex moto mmadụ site na mkpali mmekọrịta jikọtara ọnụ. Ụbụrụ 123, 572–584. 10.1093/ụbụrụ/123.3.572 [PubMed] [Cross Ref]
  89. Steffensen SC, Svingos AL, Pickel VM, Henriksen SJ (1998). Nkọwapụta eletrọnịkị nke GABAergic neurons na mpaghara ventral tegmental. J. Neurosci. 18, 8003–8015. [PubMed]
  90. Sun W., Rebec GV (2006). Nlekọta onwe nke cocaine ugboro ugboro na-agbanwe nhazi ozi metụtara cocaine na oke prefrontal cortex. J. Neurosci. 26, 8004–8008. 10.1523/jneurosci.1413-06.2006PubMed] [Cross Ref]
  91. Swanson LW (1982). Ntụle nke mpaghara ventral tegmental na mpaghara ndị dị n'akụkụ: ngwakọta fluorescent retrograde tracer na immunofluorescence ọmụmụ na oke. Brain Res. ehi. 9, 321–353. 10.1016/0361-9230(82)90145-9 [PubMed] [Cross Ref]
  92. Szabo B., Siemes S., Wallmihrath I. (2002). Mgbochi nke GABAergic neurotransmission na mpaghara ventral tegmental site na cannabinoids. Euro. J. Neurosci. 15, 2057–2061. 10.1046/j.1460-9568.2002.02041.x [PubMed] [Cross Ref]
  93. Tan KR, Brown M., Labouèbe G., Yvon C., Creton C., Fritschy J.-M., et al. . (2010). Ntọala akwara maka ihe na-eri ahụ nke benzodiazepines. Ọdịdị 463, 769–774. 10.1038/ ọdịdị08758 [PMC free article] [PubMed] [Cross Ref]
  94. Tang W., Wesley M., Freeman WM, Liang B., Hemby SE (2004). Mgbanwe na subunits ionotropic glutamate receptor subunits n'oge nchịkwa cocaine binge na mwepụ na oke. J. Neurochem. 89, 1021–1033. 10.1111/j.1471-4159.2004.02392.x [PMC free article] [PubMed] [Cross Ref]
  95. Testa-Silva G., Verhoog MB, Goriounova NA, Loebel A., Hjorth J., Baayen JC, et al. . (2010). Synapses nke mmadụ na-egosi windo ogologo oge maka ogologo oge na-adabere na plastik. N'ihu. Synapti neurosci. 2:12. 10.3389/fnsyn.2010.00012 [PMC free article] [PubMed] [Cross Ref]
  96. Testa-Silva G., Verhoog MB, Linaro D., de Kock CP, Baayen JC, Meredith RM, et al. . (2014). Mgbasa ozi synapti nke bandwidth dị elu na nsochi ugboro na neocortex mmadụ. PLoS Biol. 12:e1002007. 10.1371/journal.pbio.1002007 [PMC free article] [PubMed] [Cross Ref]
  97. Thabit MN, Ueki Y., Koganemaru S., Fawi G., Fukuyama H., Mima T. (2010). Mkpali cortical metụtara mmegharị nwere ike ịkpalite plasticity moto mmadụ. J. Neurosci. 30, 11529–11536. 10.1523/JNEUROSCI.1829-10.2010 [PubMed] [Cross Ref]
  98. Thomas MJ, Beurrier C., Bonci A., Malenka RC (2001). Ịda mbà n'obi na-adịte aka na nucleus accumbens: njikọ akwara nke mmetụta omume na cocaine. Mba. Neurosci. 4, 1217–1223. 10.1038/nn757 [PubMed] [Cross Ref]
  99. Tolu S., Eddine R., Marti F., David V., Graupner M., Pons S., et al. . (2013). Ntinye aka nke VTA DA na neurons GABA na-akwado nkwado nicotine. Mol. Isi mgbaka 18, 382–393. 10.1038/mp.2012.83 [PubMed] [Cross Ref]
  100. Ewezuga MA, Whistler JL, Malenka RC, Bonci A. (2001). Ikpughe otu cocaine na vivo na-ebute ike ogologo oge na neurons dopamine. Ọdịdị 411, 583–587. 10.1038/35079077PubMed] [Cross Ref]
  101. Ụlọ ọrụ United Nations na ọgwụ ọjọọ na mpụ (2014). Akụkọ ọgwụ ọjọọ ụwa 2014. Herndon, VA: mbipụta United Nations.
  102. Van den Oever MC, Goriounova NA, Li KW, van der Schors RC, Binnekade R., Schoffelmeer ANM, et al. . (2008). Prefrontal cortex AMPA receptor plasticity dị oke mkpa maka nlọghachi azụ na-achọ heroin. Mba. Neurosci. 11, 1053–1058. 10.1038/nn.2165 [PubMed] [Cross Ref]
  103. Van den Oever MC, Lubbers BR, Goriounova NA, Li KW, van der Schors RC, Loos M., et al. . (2010). Extracellular matrix plasticity na GABAergic mgbochi nke prefrontal cortex pyramidal cell na-eme ka nlọghachi azụ na ịchọ heroin. Neuropsychopharmacology 35, 2120-2133. 10.1038/npp.2010.90 [PMC free article] [PubMed] [Cross Ref]
  104. Van den Oever MC, Spijker S., Smit AB (2012). "Pathology synaptik nke ọgwụ riri ahụ," na Synaptic Plasticity Advances in Experimental Medicine and Biology, eds Kreutz MR, Sala C., ndị editọ. (Vienna: Springer Vienna; ), 469–491.
  105. Verhoog MB, Goriounova NA, Obermayer J., Stroeder J., Hjorth JJJ, Testa-Silva G., et al. . (2013). Usoro n'okpuru iwu maka mmekọ plasticity na ndị okenye neocortical synapses. J. Neurosci. 33, 17197–17208. 10.1523/jneurosci.3158-13.2013 [PubMed] [Cross Ref]
  106. Volkow ND, Fowler JS, Wang G.-J. (2003). Ụbụrụ mmadụ riri ahụ: nghọta sitere na ọmụmụ ihe onyonyo. J. Clin. Tinye ego. 111, 1444–1451. 10.1172/jci200318533 [PMC free article] [PubMed] [Cross Ref]
  107. Volkow N., Li T.K. (2005). The neuroscience nke iri ahụ. Mba. Neurosci. 8, 1429–1430. 10.1038/nn1105-1429 [PubMed] [Cross Ref]
  108. Washburn MS, Dingledine R. (1996). Mgbochi nke alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) ndị na-anabata ya site na polyamines na polyamine toxins. J. Pharmacol. Exp. Ebe ahụ. 278, 669–678. [PubMed]
  109. Williams JM, Galli A. (2006). Onye na-ebugharị dopamine: njikwa ókèala na-amụ anya maka omume psychostimulant. Handb. Exp. Pharmacol. 175, 215–232 . 10.1007/3-540-29784-7_11PubMed] [Cross Ref]
  110. RA maara ihe (2004). Dopamine, mmụta na mkpali. Mba. Rev. Neurosci. 5, 483–494. 10.1038/nrn1406PubMed] [Cross Ref]
  111. Wolf ME, Ferrario CR (2010). Amụma AMPA plasticity na nucleus accumens mgbe ekpughere cocaine ugboro ugboro. Neurosci. Biobehav. Mkpu. 35, 185–211. 10.1016/j.neubiorev.2010.01.013 [PMC free article] [PubMed] [Cross Ref]
  112. Wolf ME, Tseng KY (2012). Calcium-permeable AMPA anabata na VTA na nucleus accumens mgbe cocaine ikpughe: mgbe, kedu, na gịnị kpatara? N'ihu. Mol. Neurosci. 5:72. 10.3389/fnmol.2012.00072 [PMC free article] [PubMed] [Cross Ref]
  113. Wolters A., Sandbrink F., Schlotmann A., Kunesch E., Stefan K., Cohen LG, et al. . (2003). Iwu Hebbian asymmetric nwa oge na-achịkwa plasticity na cortex moto mmadụ. J. Neurophysiol. 89, 2339–2345. 10.1152/jn.00900.2002 [PubMed] [Cross Ref]
  114. Wolters A., Schmidt A., Schramm A., Zeller D., Naumann M., Kunesch E., et al. . (2005). Plasticity nke dabere na oge na cortex somatosensory nke mmadụ. J. Physiol. 565, 1039–1052. 10.1113/jphysiol.2005.084954 [PMC free article] [PubMed] [Cross Ref]
  115. Òtù Ahụ Ike Ụwa (2008). Ibu Ọrịa zuru ụwa ọnụ: Mmelite 2004. Geneva: Òtù Ahụ Ike Ụwa.
  116. Yuan T., Mameli M., O'Connor EC, Dey PN, Verpelli C., Sala C., et al. . (2013). Ngosipụta nke plastik synapti nke cocaine sitere na GluN3A nwere NMDA ndị nnata. Neuron 80, 1025-1038. 10.1016/j.neuron.2013.07.050 [PubMed] [Cross Ref]
  117. Zweifel LS, Argilli E., Bonci A., Palmiter RD (2008). Ọrụ nke ndị na-anabata NMDA na neurons dopamine maka plasticity na omume riri ahụ. Neuron 59, 486–496. 10.1016/j.neuron.2008.05.028PMC free article] [PubMed] [Cross Ref]